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ABSTRACT 
 
A mouse lymphatic endothelial cell (SVEC4-10) model and a human intestinal cell 
(C2BBe1) model in vitro were developed and capable to be used to study antioxidant activity, 
hypocholesterolemic capability and digestibility of γ-oryzanol. The critical and vital parameters 
in developing these cell models were the emulsion preparation of hydrophobic compounds for 
cell models, the consistent management of cell culture, and the selection of cell viability 
detection methods compatible with the cell lines and the test substances. The results showed that, 
in some situations, γ-oryzanol could present a more effective antioxidant activity than α-
tocopherol, in terms of reducing tert-butyl hydroperoxide promoted oxidative damage on cellular 
mitochondrial activity. After 1-hour oxidation, cell viability was 81.8% when incubated with γ-
oryzanol, compared to 54.5% with the control and 74.6% with α-tocopherol. The three major 
components of γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and 
campesteryl ferulate, generally had higher antioxidant activity than γ-oryzanol and among them, 
24-methylene cycloartanyl ferulate was found to be relatively more effective and could be more 
powerful than α-tocopherol. A synergistic antioxidant activity among γ-oryzanol, ferulic acid 
and α-tocopherol was also found. With regard to the hypocholesterolemic capacity of γ-oryzanol, 
the results suggested that the intact γ-oryzanol was poorly absorbed by intestinal cells in vitro. 
Therefore, it was speculated that the effect of γ-oryzanol might take place in the lumen of 
gastrointestinal tract, possibly by means of reducing the micellar solubility of cholesterol and 
cholesteryl esters and inhibiting cholesterol esterase-facilitated cholesteryl ester hydrolysis. The 
results showed that preincubation of cholesterol and γ-oryzanol for six hours significantly 
reduced the cholesterol uptake into cells. γ-Oryzanol also showed a trend towards inhibition of 
cholesteryl esterase, which is responsible for hydrolyzing cholesteryl esters to free cholesterol 
  xi 
before uptake. The results of in vitro digestibility studies of γ-oryzanol showed that the ester 
bond of γ-oryzanol, especially campesteryl ferulate and sitosteryl ferulate, was broken down by 
cholesterol esterase and produced triterpene alcohols or sterols and ferulic acid, which were 
further degraded. The degradation of γ-oryzanol in the stomach may undergo a different pathway 




CHAPTER 1. INTRODUCTION 
 
While the international scientific research community has recognized the health 
promoting potential of rice bran for many years, the rice-processing industry in the United States 
has just recently begun to explore and develop its commercially feasible utilization. In this study, 
the background of γ-oryzanol and rice bran including sources, analytical methods, toxicity, 
metabolism and potential functionality was reviewed (Chapter 2). 
γ-Oryzanol has been suggested to have potential functionality such as 
hypocholesterolemic capability and antioxidant activity. The goal of this study was to develop 
cell culture models as tools to study these two potential aspects of functionality (Chapter 3 and 
Chapter 4) and digestibility (Chapter 5) of γ-oryzanol. Using cell culture models enables us to 
speculate and monitor a particular biochemical reaction to a certain cell type in humans in a less 
expensive and invasive way.  
γ-Oryzanol components have been found to have higher antioxidant activity than vitamin 
E components in some chemical models. One of the objectives was to determine the antioxidant 
activity of γ-oryzanol and its three major components, cycloartenyl ferulate, 24-methylene 
cycloartanyl ferulate and campesteryl ferulate, and compare them to ferulic acid and α-
tocopherol using tert-butyl hydroperoxide (tBHP) induced oxidation on an in vitro mouse 
lymphatic endothelial cell (SVEC4-10) model. The critical conditions to develop a cell culture 
model and the effects of γ-oryzanol incorporation with cells before tBHP oxidation on its 
antioxidant activity and synergistic antioxidant activity with ferulic acid and α-tocopherol were 
also discussed. 
Some studies have shown that the serum and liver cholesterol levels in rats were lowered 
after the consumption of rice bran oil or dietary γ-oryzanol feeding. Another objective of this 
  
2 
study was then to explore the hypocholesterolemic effects of γ-oryzanol focusing on cholesterol 
uptake into human intestinal cells (C2BBe1) in vitro. It has been believed that a reduced 
cholesterol uptake or an increase of fecal cholesterol excretion would correspond to decreased 
serum total cholesterol levels and the cholesteryl esters in the gastrointestinal lumen should be 
hydrolyzed by cholesterol esterase before absorption. Hence, the functions of γ-oryzanol on 
cholesterol uptake into C2BBe1 cells in vitro investigated in this study were the effects of γ-
oryzanol on reducing micellar solubility of cholesterol and cholesteryl esters and on inhibiting 
cholesterol esterase-facilitated cholesteryl ester hydrolysis. 
Additionally, there has been little information published in regard to the digestibility, the 
metabolic fate and toxicity of digest products and metabolites of γ-oryzanol in humans. To 
further understand where the functionality of γ-oryzanol takes place and how it functions relies 
on the fate of γ-oryzanol after ingestion. Therefore, digestibility of γ-oryzanol with emphasis on 
peptic and pancreatic digestions and the effect of three pancreatic enzymes, cholesterol esterase, 




CHAPTER 2. LITERATURE REVIEW 
 
2.1 Rice Bran and Oryzanol 
Rice bran is a relatively abundant byproduct of rice milling. Rice bran oil for food use 
produced commercially in the United States started in 1994, while it has been extensively 
consumed in many Asian countries. The annual world rice bran oil production is estimated to be 
less than 800,000 metric tons or about only 1% of all vegetable oils (McCaskill and Zhang, 
1999). With the rising awareness of functional food consumption, the demand, value and 
production are expected to be higher. 
A rice kernel consists of 20% hull, 72% endosperm, 6% bran, and 2% germ (Figure 2.1) 
(Juliano and Bechtel, 1985; Lu and Luh, 1991). Rice bran is the soft germ and several soft layers, 
pericarp, seed coat, nucellus and aleurone layer, surrounding the hard starchy endosperm.  Rice 
bran contains 15-20% oil, generally the same as soybeans, 12-16% proteins, 34-52% available 
carbohydrates, 7-11% crude fiber, and 7-10% ash. The typical crude rice bran oil is composed of 
68-71% triacylglycerols, 2-3% diacylglycerols, 5-6% monoacylglycerols, 2-3% free fatty acids, 
5-7% glycolipids, 3-4% phospholipids (mainly phosphatidylcholine, phosphatidylethanolamine 
and phosphatidylinositol), 2-3% waxes, and 4.2% unsaponifiable fraction (McCaskill and Zhang, 
1999; Sayre and Saunders, 1990). Free fatty acids, monoacylglycerols and diacylglycerols are 
associated with enzymatic hydrolysis. Sterols, existing as free or esterified, are the major portion 
in the unsaponifiable fraction and classified as 1) 4-desmethylsterols, i.e. normal phytosterols 
without methyl groups at C-4 position; 2) 4-monomethylsterols and 3) 4,4’-dimethylsterols, also 
known as triterpene alcohols. Rice bran oil contains more non-triacylglycerol components than 
most vegetable oils but these are lost during refining processes. 
Figure 2.1. Rice kernel structure adapted from Orthoefer, 1996
  
Oryzanol occurs in the unsaponifiable fraction of rice bran oil and is so named because it 
was first discovered in rice bran oil (Orysae Sativa L.) (Kaneko and Tsuchiya, 1954) and 
contained a hydroxyl group. Oryzanol was originally considered a single compound but later was 
determined to be a mixture of ferulic acids esterified with normal sterols or triterpene alcohols, 
called α-, β- and γ-oryzanol, of which γ-oryzanol has been the most commonly mentioned. The 
sterol components of γ-oryzanol are primarily campesterol and sitosterol, and the triterpene 
alcohol components are cycloartenol and 24-methylene cycloartanol (Figure 2.2(b)). The content 
of γ-oryzanol in rice bran oil can range from 1-3% (Seetharamaiah and Prabhakar, 1986), 
depending on the rice varieties and analytical methods. The most accessible natural source of γ-
oryzanol is rice bran, but some components of γ-oryzanol, mainly sitostanyl ferulate and 
campestanyl ferulate and lesser amounts of sitosteryl ferulate and campesteryl ferulate, can also 
be found mostly in the inner pericarp of corn, wheat, rye and triticale grains (Seitz, 1989).  
2.2 Biological Aspect of γ-Oryzanol 
The biological function of γ-oryzanol in the plant has not been clearly described. Since it 
is a mixture of ferulate esters with sterols or triterpenes, one may view it from two standpoints, 
triterpenes or sterols and ferulic acid. Triterpenoids can be categorized under the class 
synonymously named terpenoids, terpenes or isoprenoids, which are various, widespread and 
numerous natural products derived from a common biosynthetic pathway based on mevalonate 
as the parent compound, with the important subclass of steroids (Banthorpe, 1991). The general 
pathway of biosynthesis (Figure 2.3) is enzymatically controlled and starts from acetyl-CoA, to 
mevalonate, to 2E,6E-farnesyl pyrophophate, to squalene, and then to triterpenoids, with a final 
chair-boat-chair-boat configuration (Bramley, 1997). Phytosterols are further formed from 



















































Figure 2.2. Chemical structures of (a) a sterol with carbon numbering,
(b1)-(b10) γ-oryzanol components and (c) cholesterol
Figure 2.2. Chemical structures of (a) a sterol with carbon numbering,








































the removal of three methyl groups in the sequence C-4, C-14 and then C-4 ((see Figure 2.2(a) 
for numbering system according to IUPAC-IUB (1989); Bramley (1997); and Goad (1991)). The 
initial pathway from acetyl-CoA to squalene is common to all organisms, but the sequence of the 
modifications of the sterol ring system and side chain can differ from species or even in various 
tissues or during different developmental stages in a plant. Sterol production supposedly occurs 
in the cytosolic and microsomal compartments of the plant cells. 
Phytosterols play a structural role in plant cells as an essential membrane constituent by 
analogy with cholesterol in animal cells (Goad, 1991), which regulates its fluidity and enhances 
the mechanical stability of the membrane. The plasma membrane has the highest level of sterols 
and the greatest ratio of sterol:phospholipid. The endoplasmic reticulum has a lower content and 
the mitochondrial and the chloroplast membranes contain a small amount of free sterol. Sterols 
are important for plant growth in two ways. One is for new membrane production by dividing 
cells and the other is for a 24-ethylsterol such as stigmasterol for specific stimulatory function 
for cell division to proceed. 
On the other hand, ferulic acid is initially converted from phenylalanine and tyrosine by 
enzymes (Figure 2.4) (Graf, 1992) and much of the ferulic acid occurs as esters in many plants, 
which may imply the pathway further undergoes conjugation with other molecules. The 
biological role of ferulic acid has been suggested to crosslink some cell components and lower 
their availability to hydrolytic degradation by endosperm enzymes and thus inhibit germination. 
In addition, some studies imply a defensive role of ferulic acid with repellent property and a 












Figure 2.4. Brief metabolic pathways of ferulic acid formation 
in plants
  
2.3 Development of γ-Oryzanol Analysis 
It has been established that γ-oryzanol is a mixture and the number of individual 
components found in γ-oryzanol depends on the chromatographic approaches. Normal-phase 
high performance liquid chromatography (HPLC) used by Diack and Saska, 1994, could only 
separate γ-oryzanol into two fractions and each fraction contained at least two or more 
constituents. Identification and quantification of each individual component of γ-oryzanol would 
be difficult due to incomplete separation. Reverse-phase HPLC, on the other hand, could identify 
five (Norton, 1995) or six (Evershed et al., 1988; Rogers et al., 1993) individual components of 
γ-oryzanol. Furthermore, Xu and Godber, 1999, successfully separated and identified ten 
components of γ-oryzanol from rice bran oil using preparative normal-phase HPLC to 
concentrate γ-oryzanol and to reduce interfering substances and reverse-phase HPLC to isolate 
and collect each component (Figure 2.5). These ten components were identified as ∆7-
stigmastenyl ferulate, stigmasteryl ferulate, cycloartenyl ferulate, 24-methylenecycloartanyl 
ferulate, ∆7-campestenyl ferulate, campesteryl ferulate, ∆7-sitostenyl ferulate, sitosteryl ferulate, 
campestanyl ferulate and sitostanyl ferulate (see Figure 2.2(b) for chemical structures). The three 
major components among these are cycloartenyl ferulate, 24-methylenecycloartanyl ferulate and 
campesteryl ferulate. 
2.4 Influence of Rice Bran and Rice Bran Oil Processing on γ-Oryzanol 
After milling, hydrolytic rancidity by enzymes in the bran occurs rapidly. Methods 
developed to accomplish stabilization are heating with an extruder or microwave oven, freezing 
and treating with chemicals. Therefore, after being abraded during rice milling, bran is 
commonly stabilized by extrusion to inactivate the indigenous lipase and prevent further 
hydrolysis and the production of free fatty acids and glycerol.  
Figure 2.5. HPLC chromatogram of γ-oryzanol from Xu and Godber, 
1999
1. ∆7-stigmastenyl ferulate, 
2. stigmasteryl ferulate, 
3. cycloartenyl ferulate, 
4. 24-methylenecycloartanyl ferulate, 
5. ∆7-campestenyl ferulate, 
6. campesteryl ferulate, 
7. ∆7-sitostenyl ferulate, 
8. sitosteryl ferulate, 
9. campestanyl ferulate, and 

















The stability and storability of γ-oryzanol in rice bran after extrusion has been studied by 
Shin et al., 1997. Rice bran was extruded at temperatures ranging from 110 to 140oC with post 
extrusion holding times 0, 3, and 6 minutes. γ-Oryzanol, total vitamin E and free fatty acids 
contents were detected after each treatment at 0 and 7 to 375 days of storage time. It was found 
that the post extrusion holding time had no effect on hydrolytic stability and the extrusion 
temperature at 110oC was less effective. The loss of γ-oryzanol and total vitamin E increased 
when the extrusion temperature increased, which were in a temperature-dependent manner, but 
the degree of total vitamin E loss was greater than that of γ-oryzanol loss. The total vitamin E 
content decreased when the holding time increased, while γ-oryzanol content decreased only 
after 6 minutes of holding time. Additionally, during storage after extrusion, most of the total 
vitamin E was lost by 210 days of storage, while the degradation rate of γ-oryzanol was constant 
and more than one third of γ-oryzanol was still present throughout storage. In summary, γ-
oryzanol was more stable than vitamin E to the heat of extrusion and decomposition after 
extrusion during one year of storage at ambient temperature. 
After rice bran stabilization, crude rice bran oil is extracted and then refined before 
human consumption. The process of rice bran oil refining usually involves degumming, 
neutralization, bleaching, deodorization, and hydrogenation. It has been reported that, in general, 
the total sterol loss after oil refining may be between 10 to 70%, depending on the type of oil and 
the processing conditions employed, and the sterol content gradually decreases in each step of 
the refining process (Kochhar, 1983).  
In the neutralization step, the use of alkali such as caustic soda (NaOH) to remove free 
fatty acids forms soapstock with a significant amount of γ-oryzanol, which is later separated by 
settling or centrifugation. The soapstock can be reacidified to yield dark acid oil, in which the 
  
free fatty acids can be distilled under high vacuum and leaves γ-oryzanol in the residue called 
pitch. It has been proposed to recover γ-oryzanol from the inexpensive pitch as a valuable 
byproduct (Das et al., 1998). In the bleaching step, the purpose is to remove color materials by 
heating to 85oC and treating with adsorbants such as activated carbon and activated bleaching 
earth. It has been recorded that partial modification of sterols, i.e. dehydration and oxidation, and 
deacylation of sterol esters may occur during bleaching. In the deodorization step to remove 
volatile compounds with undesirable flavors, steam distillation under reduced pressure is usually 
used with the expectation that nonvolatile off-flavor substances will be thermally degraded, 
become volatile and be distilled away.  
Finally, the hydrogenation process, which is important in the oil industry, allows the 
liquid oils to be converted into semisolid or solid fats for special applications such as margarine. 
The process is to add hydrogen to double bonds in the fatty acid chains, which are susceptible to 
oxidation, and thus also improves the oxidative stability of the oil. The effect of bleaching, 
deodorization and hydrogenation on γ-oryzanol content in refined oil has not been clearly 
studied, which may be related to the fact that γ-oryzanol is mainly lost after neutralization. 
However, since it has been noted that γ-oryzanol has several double bonds and possesses 
antioxidant activity, if it survives neutralization, γ-oryzanol content may further decrease during 
these steps where oxidation may occur. 
Not only γ-oryzanol but also tocotrienols are lost during each step of rice bran oil refining 
process, and after processing, up to 90% can be lost. This implies that new refining methods for 
rice bran oil must be developed and the recoveries of these beneficial ingredients must be well 
optimized in order to increase the value of rice bran oil. 
  
2.5 Toxicology and Carcinogenicity Studies of γ-Oryzanol 
The safety of γ-oryzanol for human consumption was tested by toxicology studies on rats 
fed a diet containing 10% rice bran oil compared to groundnut oil for three generations 
(Rukmini, 1988). The chemical composition between these two oils was similar, except the 
unsaponifiable matter of rice bran oil (4.1%) was higher. The rice bran oil effect on the growth 
performance, including weight gain and feed efficiency, was not significantly different and the 
effect on fat absorption and the retention of nitrogen, phosphorus and calcium was not 
significantly different. Moreover, the toxicological effect of rice bran oil on reproductive 
performance was evaluated for two matings and three generations. The results indicated that no 
abnormalities were found, which were comparable to groundnut oil groups on the percentage of 
conception, birth weight, litter size, weaning weight, preweaning mortality and the number of 
days taken to deliver from the date of introduction for mating. The mutagenic potential of rice 
bran oil for deep frying and repeated heating was also found to be negative, which demonstrated 
remarkable oxidative stability. 
Furthermore, the short-term safety of γ-oryzanol was assessed using the Rec assay 
(bacterial DNA repair test), the Ames test (bacterial reverse mutation test), the rat bone marrow 
chromosome aberration test, and the metabolic cooperation inhibition test using Chinese hamster 
V79 cells (Tsushimoto et al., 1991). γ-Oryzanol showed negative responses to all these tests.  
Additionally, potential carcinogenesis of γ-oryzanol was studied by feeding mice a diet 
containing γ-oryzanol up to 2g/kg body weight/day for 78 weeks (Tamagawa et al., 1992b) and 
feeding rats for 2 years (Tamagawa et al., 1992a). No treatment-related change was found in 
general condition, food consumption, mortality, organ weight and hematology. Histopathological 
  
examination showed that the tumor incidents were not significantly different between the treated 
groups and the control groups. 
Modifying effects of γ-oryzanol were also studied in a rat wide-spectrum organ 
carcinogenesis model (Hirose et al., 1991). The three combined carcinogens used were 2,2’-
dihydroxy-di-n-propylnitrosamine (1g/kg body weight ×2 i.p. injections), N-etyhl-N-
hydroxyethylnitrosamine (1.5g/kg body weight ×2 i.g. administration) and 3,2’-dimethyl-4-
aminobiphenyl (75mg/kg body weight ×3 subcutaneous injections) treatment at intervals of 3 to 
4 days. One week after the combined treatment, the animals were fed a basal diet containing 1% 
γ-oryzanol for 32 weeks and then sacrificed for complete autopsy. The results showed that the γ-
oryzanol treatment tended to lower the incidences of pancreatic eosinophilic foci and liver 
hyperplastic nodule and hepatocellular carcinoma, but increased the incidences of lung adenoma 
and carcinoma. However, the 1% γ-oryzanol dose given in their study was 100 to 150 times 
higher than what γ-oryzanol is usually given for medical use (>300mg/person/day). Also, the 
correlation between γ-oryzanol ingestion and human lung cancer and the interaction with other 
ingredients in the diet have not been reported in any epidemiological data.  
On the other hand, another study of modifying effects on carcinogenesis was 
demonstrated using a similar animal model (Imaida et al., 1990) but with two different combined 
carcinogens, 1,2-dimethylhydrazine (40mg/kg body weight ×3 subcutaneous injections within 
one week) and 1-methyl-1-nitrosourea (20mg/kg body weight ×2 i.p. administrations, twice a 
week for 2 weeks). The animals were then on a diet containing 1% ferulic acid until autopsy at 
the 52nd week. The combined carcinogens could cause initiation in many organs such as 
forestomach, glandular stomach, alimentary tract, urinary bladder, kidney, lung, nervous system, 
mammary gland and hematopoietic system and induce colon carcinomas in rats. The results 
  
showed that 1% ferulic acid had weak inhibitory effect and did not promote lung adenoma and 
carcinoma as γ-oryzanol did in the study by Hirose et al. (1991).  
Finally, γ-oryzanol and its four major components, cycloartenyl ferulate, 24-methylene 
cycloartanyl ferulate, campesteryl ferulate and sitosteryl ferulate have been reported to have an 
inhibitory effect on tumor promotion in two-staged carcinogenesis in mouse skin (Yasukawa et 
al., 1998). Both the inner and outer surfaces of the ear of each mouse were treated topically with 
γ-oryzanol and its components at different concentrations, followed by 12-O-
tetradecanoylphorbol-13-acetate (TPA) (1µg/ear) to induce inflammation. The ear thickness was 
determined to compare the anti-inflammatory activities. The results showed that, while γ-
oryzanol had no significant effect, its four components had inhibitory activities in a 
concentration-dependent manner. Their 50% inhibitory dose was lower than quercetin, a known 
tumor inhibitor, similar to indomethacin and higher than hydrocortisone. The inhibitory ratio was 
higher than quercetin and comparable with indomethacin and hydrocortisone. Furthermore, the 
TPA promoting effect on papillomas induced by 7,12-di-methylbenz[a]anthracene was 
remarkably inhibited by cycloartenyl ferulate. Esterification of triterpenes with ferulic acid had 
no influence, but sitosteryl ferulate was found more effective than free sitosterol. Interestingly, 
the topical application of γ-oryzanol was found to significantly increase sebaceous secretion of 
the skin, turnover of sebaceous gland cells and peripheral blood flow, which indicated that γ-
oryzanol may be useful to repair damaged or dry skin. In fact, γ-oryzanol has been used in skin 
lotion for its cosmetic and pharmaceutical effects. 
In summary, γ-oryzanol has been approved and commercially available in many countries 
such as Japan but government and industry in the United States are comparably more 
conservative. Studies suggest that γ-oryzanol is not carcinogenic to animals and rice bran oil was 
  
safe for human consumption. There have been no reported acute or chronic side effects of γ-
oryzanol and the evidence of its beneficial effects in humans is increasing and the market is 
growing. Thus, extensive and well-designed clinical trials with regard to the potential of γ-
oryzanol and ferulic acid as chemopreventors or promoters and the mechanisms for carcinogenic 
or anticarcinogenic effects are needed.  
2.6 Digestibility, Absorption and Metabolism of γ-Oryzanol  
While γ-oryzanol has been utilized in many countries as food additives and 
pharmaceuticals, there are only a few studies in English exploring the digestibility of γ-oryzanol 
in the human gastrointestinal tract. Many of the studies used animal models such as rabbits and 
rats and they were also done using thin layer chromatography in the period when the analytical 
method to identify γ-oryzanol and its metabolites was not advanced. 
One of the few studies about absorption, metabolism and lymphatic transport of γ-
oryzanol -14C orally administered to rats (50 mg/kg) was by Fujiwara et al., 1983. After 72 hours 
of administration, 9.8% radioactivity was found in urine and 84.5% was in feces. That found in 
the urine was not intact γ-oryzanol but identified as the major metabolites such as ferulic acid, 
dihydroferulic acid, m-hydroxyphenylpropionic acid, m-coumaric acid, m-hydroxyhippuric acid, 
hippuric acid (see Figure 2.6 for chemical structures) and also their conjugated forms with 
glucuronide or sulfate. In their experiment of in situ absorption at the mid-ileal portion of the 
intestines, the results showed that 89.4% of the dose remained in the luminal fluid with more 
than 95% intact and only 0.2% found in mesenteric vein as intact esters, which suggests that γ-
oryzanol was poorly absorbed. Additionally, it was also found that only 0.3% of the dose was 
transported into the thoracic duct, of which more than 80% was intact γ-oryzanol by thin layer 






























Figure 2.6. Chemical structures of ferulic acid and its urinary 
metabolites as reported in Fujiwara et al., 1983, and 







administration mainly went through the portal vein system instead of the lymph via the thoracic 
duct. In their study, the radioactivity found in feces was not tested as to whether it was the intact 
γ-oryzanol or its metabolites. It was reported that the ester linkage of γ-oryzanol was partly 
hydrolyzed in the intestine during absorption; however, the digestibility of γ-oryzanol going 
through the stomach, duodenum and jejunum was not discussed.  
Even though the digestibility of γ-oryzanol has not been fully studied, absorption of plant 
sterols by the human body has been investigated. It was found that the plasma levels of plant 
sterols were very low, approximately only 5% of ingested plant sterols are absorbed, and 
suggested that the absorption was limited, except for those with a rare genetic disorder, 
sitosterolemia, which increases the absorption rate of plant sterols (Moghadasian, 2000). The 
accumulation of sitosterol in plasma and tissues of a sitosterolemic patient accounted for the 
increased sitosterol absorption rate and the decreased elimination rate and symptoms include 
tendon xanthomas, accelerated atherosclerosis, hemolytic episodes, arthritis and arthralgias and 
was observed mostly in young males. 
Therefore, to fully understand the fate of γ-oryzanol in the human digestive system, 
further research is required. In this study, the in vitro digestibility of γ-oryzanol by pepsin and 
pancreatic enzymes such as cholesterol esterase, phospholipase A2 and lipase was inspired and 
the absorbability of γ-oryzanol was demonstrated in a human intestinal cell model.  
2.7 In Vitro Cell Culture Models 
Tissue culture, commonly used as a generic term to refer to organ culture and cell culture 
as well as tissue culture, was first devised at the beginning of the 20th century. The term cell 
culture implies a culture derived from dispersed cells taken from original tissue or from a cell 
line. Tissue culture techniques can be applied for studies in toxicology, virology, immunology, 
  
cancer research and so on. The advantages of tissue culture are control of physiochemical 
environment (pH, temperature, O2) and physiological conditions (hormone, nutrients), 
production of homogeneous culture to reduce variance, avoidance of the ethical questions of 
animal experimentation, and economic with availability of microtitration and robotics and with 
direct access to the cell and consequently less use of reagent. 
2.7.1 Cell Selection 
To select a cell line, besides the specific function to be studied, there are a number of 
parameters to be considered (Freshney, 2000): 1) Finite or continuous cell line; a continuous cell 
line usually grows faster and is easy to maintain. 2) Normal or transformed cell line. 3) Species; 
non-human cell lines are more accessible and have fewer biohazard restrictions. 4) Growth 
characteristics such as population-doubling time, yield and cloning efficiency. 5) Availability. 6) 
Validation; how well the cell line is characterized as acceptable. 7) Phenotypic expression; if the 
cell line is made to express the right characteristics. 8) Control cell line; if a normal equivalent 
cell line is required when using a transformed or abnormal cell line. 9) Stability; how the cell line 
is stable and can be generated into sufficient frozen and usable stocks. 
However, there are also limitations in developing and using in vitro cell models. One is 
the requirement of expertise due to the strict aseptic culture conditions to avoid chemical or 
microbial contamination and the handling of biohazard disposal. Secondly, cells may lose the 
phenotypic characteristics and not function as they should. Many continuous cell lines may also 
show variability from passage to passage. Other limitations include the loss of cell-cell 
interactions and homeostatic regulations from nervous and endocrine systems and the alteration 
of energy metabolism, which may result in cell behavior change and not be truly representative 
of the tissue from which the cells were isolated. Even though limitations exist, there are many 
  
specialized functions expressed and cell culture can still be a valuable tool if the limits are 
appreciated. 
Cell culture techniques have been used to investigate antioxidant activities and 
cholesterol absorption. The cell lines that have been utilized for antioxidant activity studies 
include rat hepatocytes (Halpner et al., 1998), bovine aortic and pulmonary artery endothelial 
cells (Kapiotis et al., 1997 and Podhaisky et al., 1997), human aortic endothelial cells (Pearson et 
al., 1998) and human umbilical vein endothelial cells (Kaneko et al., 1993). The cell lines that 
have been used for cholesterol uptake studies include human intestinal cells, Caco-2, (Mackay et 
al., 1997 and Lopez-Candales et al., 1993) and rat intestinal cells (Young and Hui, 1999). In this 
study, because of its availability, growing efficiency and established utility, a mouse endothelial 
cell line (SVEC4-10) derived from axillary lymph node vessels was used to examine antioxidant 
activity of γ-oryzanol and a human intestinal cell line (C2BBe1) was used to investigate the γ-
oryzanol effect on cholesterol uptake.  
2.7.2 Cell Viability Assays 
Cell viability assays are immediate or short-term responses from cells such as a variation 
in membrane permeability or a disturbance of a particular metabolic pathway, usually obtained 
when they encounter a new environment of interest. There are several assays available, which 
have been described in many publications (i.e. antioxidant activity studies), including dye 
exclusion, crystal violet assay, lactate dehydrogenase (LDH) assay and [3-(4,5-Dimethylthiazol-
yl)-2-5-Diphenyltetrazolium Bromide (MTT) assay. 
Dye exclusion is a basic technique often employed in routine practice. Trypan blue is 
usually used and is impermeable to viable cells. However, this method does not always predict 
ultimate survival and tends to overestimate viability. The crystal violet assay is a fixed cell 
  
staining. It is inexpensive and easy to use but it nonspecifically stains protein, which may not 
necessarily measure cell viability. The LDH assay is a method used to evaluate cell viability in 
terms of the degree of cell membrane integrity. An LDH assay kit can be purchased 
commercially. It is used to detect LDH released from surviving or dead cells. The MTT assay is 
a widely chosen method to estimate the number of viable cells, whose mitochondrial 
dehydrogenases can reduce the yellow tetrazolium dye to a purple formazan product. The 
selection of viability assay depends on availability and avoidance of reacting with the test 
substances. 
2.8 Emulsion Preparation for γ-Oryzanol and Lipophilic Substances 
Since γ-oryzanol is not water soluble, it has been a challenge to prepare physiological 
aqueous solutions containing γ-oryzanol and other hydrophobic or lipophilic substances for cell 
culture studies. Emulsifiers or surfactants are usually involved, which function to create surface-
tension gradients and to deform the interface. They are amphipathic compounds, which contain 
both polar and nonpolar regions. Many biomolecules are amphipathic such as proteins, 
phospholipids and bile salts. When dispersed in water, the lipid portions force surrounding water 
molecules to become highly ordered and clusters of lipid molecules are formed. Then all 
hydrophobic groups are sequestered from water and form a stable structure called micelles with 
the hydrophobic regions inside by the force of hydrophobic interaction and the hydrophilic 
regions at the surface.  
Micelle formation plays very important roles in digestion, mobilization and transport of 
lipids. Before being absorbed through the intestinal wall, dietary lipids must be converted to 
finely dispersed microscopic micelles with the help of amphipathic compounds, i.e. bile salts, 
such as taurocholate acting as biological detergents. Bile salts are synthesized from cholesterol in 
  
the liver, stored in the gallbladder and released into the duodenum. The formation of micelles 
increases the action of water-soluble lipase to convert triacylglycerols into monoacylglycerols, 
diacylglycerols, free fatty acids and glycerol, which can diffuse into the epithelial cells lining the 
intestinal surface (the intestinal mucosa). Those lipase products are then reconverted to 
triacylglycerols and incorporated with dietary cholesterol and apolipoproteins into chylomicrons. 
Apolipoproteins, also amphipathic, are lipid-binding proteins in the blood responsible for the 
transport of triacylglycerols, phospholipids, cholesterol and cholesteryl esters between organs. 
Chylomicrons travel through the lymphatic system and bloodstream to tissues and form several 
classes of lipoproteins named very low-density lipoproteins (VLDL), low-density lipoproteins 
(LDL) and high-density lipoproteins (HDL), according to the combinations of lipids that change 
constantly and cause different densities. 
Therefore, phosphatidylcholine and bovine serum albumin were used to prepare γ-
oryzanol emulsion to demonstrate the antioxidant effect of γ-oryzanol on protecting against 
oxidative stress to mouse lymphatic endothelial cells. Oleic acid, 1-monoolein, 
phosphatidylcholine and sodium taurocholate were used to prepare micelles containing γ-
oryzanol to study γ-oryzanol digestibility and hypocholesterolemic capacity of γ-oryzanol taking 
place in human intestinal cells. 
2.9 The Potential Functionality of γ-Oryzanol to Human Health 
The concepts of food and nutrition are changing from a focus on preventing hunger and 
adverse effects on health and improving nutrition for health maintenance to a recognition that 
food may reduce morbidity and mortality from chronic diseases such as cardiovascular disease, 
cancers and obesity. Therefore, the science of functional foods, defined as nutrients or non-
nutrients that play a role in affecting one or more targeted functions in the body in a positive way 
  
(i.e. preventing disease) beyond the prevention or correction of nutrient deficiency, is becoming 
an emerging field. The term chemoprevention is sometimes used with emphasis on the function 
to decrease the incidence of disease by using specific chemicals, either alone or in combinations. 
Requirements would be that they lack significant toxicity and are easy to be supplemented for 
large sections of the populations. 
γ-Oryzanol has been suggested to have potential functionality such as antioxidant activity 
(Xu and Godber, 2001), reduction of serum cholesterol (Sasaki et al., 1990), reduction of 
cholesterol absorption and decrease of early atherosclerosis (Rong et al., 1997), inhibition on 
platelet aggregation (Seetharamaiah et al., 1990) and inhibition of tumor promotion (Yasukawa 
et al., 1998). Hence, this study was inspired to focus on the functionality of γ-oryzanol including 
antioxidant activity and hypocholesterolemic capacity and the possible mechanisms of actions as 
determined using in vitro cell culture models. 
2.9.1 Antioxidant Activity 
In order to understand the function of antioxidants, first of all, the oxidative stress caused 
by the generation of reactive oxygen species (ROS) associated with the presence of oxygen even 
under physiological conditions and the antioxidant defense system in human organisms must be 
discussed. ROS are either radicals, atoms or a group of atoms that contain at least one unpaired 
electron, such as peroxyl radicals (ROO•), hydroxyl radicals (•OH−), the nitric oxide radical 
(NO•) and the superoxide anion radical (O2•−), or non-radical compounds, such as hydrogen 
peroxide (H2O2) and singlet oxygen (1O2), which are capable of oxidizing molecules. ROS may 
have positive, negative or zero charge and sometimes are also called oxidants or prooxidants. 
The origins of ROS can be from normal human metabolism (endogenous source) starting 
with O2•−, generated by enzymatic one-electron reduction of O from xanthine oxidase, NADPH 
  
oxidase, and other reactive intermediates such as H2O2 and •OH−. The other endogenous source 
of ROS is generated as part of the primary immune defense by phagocytic cells such as 
neutrophils, monocytes or macrophages, which synthesize large amounts of O2•− and NO• 
against foreign organisms. Human organisms are also exposed to ROS (external sources) such as 
diet, cigarette smoke and ozone due to air pollution. 
The antioxidant defense system in vivo includes enzymatic and non-enzymatic 
antioxidants, which are defined as any substances that in a relatively low concentration compared 
with substrate significantly delay or inhibit the oxidation of that substrate. The major enzymatic 
antioxidants are superoxide dismutase (O2•−→ H2O2), catalase (H2O2→ H2O), glutathione 
peroxidase (organic hydroperoxides ROOH→ H2O) with glutathione (GSH→GSSH), 
glutathione reductase to restore GSH from GSSH, glutathione-S-transferases (conjugation with 
some reactive intermediate products) and metal-binding proteins (ferritin and transferrin, 
prevention of initiation of lipid peroxidation or DNA damage).  
The non-enzymatic antioxidants are dietary antioxidants among which the most 
prominent are ascorbic acid (vitamin C), tocopherols and tocotrienols (vitamin E), carotenoids 
and flavonoids. Vitamin C acts as a scavenger of ROS, is most effective against O2•−, H2O2, 
•OH− and 1O2, and forms ascorbyl radical. Vitamin E is a scavenger of ROO• , is more important 
in inhibiting lipid peroxidation, and yields tocopheroxyl radical, which is less reactive and acts as 
a chain-breaking antioxidant. Carotenoids are natural colorants and scavengers of 1O2 and ROO• 
(physical quenching by energy transfer and chemical quenching by interaction with radicals). 
Flavonoids are polyphenolic antioxidants that can scavenge ROO• , O2•− and •OH− and form 
phenoxy radicals. 
  
It has been suggested that ROS are involved in numerous diseases such as cardiovascular 
diseases, cancer, cataract and age-related macular degeneration, neuronal diseases and so on. For 
example, the main cause of many cardiovascular diseases is thought to be atherosclerosis in the 
artery wall, which is fatty streaks containing large cytoplasmic lipid deposits of free and 
esterified cholesterol formed in the subendothelial space. This occurs by way of aggregation of 
foam cells, which are of macrophage origin, with smooth muscle cells comprising the rest. There 
is increasing evidence that LDL oxidation initiated by radicals is responsible for the pathogenic 
pathway and lipophilic antioxidants such as α-tocopherol are very effective to inhibit LDL 
oxidation. Therefore, antioxidants play important roles in preventing oxidative damage to bodily 
functions and dietary antioxidant intake is expected to lower the risk of a number of ROS-related 
diseases. 
Direct measurement of prooxidants in vivo is difficult; however, there are many studies 
that have established using in vitro models in order to speculate relative to in vivo antioxidant 
action. Generally, the models constructed to study antioxidant activity of a compound or mixture 
consist of three parts: 1) ROS generators to initiate oxidation reactions, i.e. 2,2’-azobis(2-
methylpropionamidine) dihydrochloride (AAPH), 2,2’-azinobis(3-ethylbenzothiazoline-6-
sulfonic acid (ABTS•+), 2,2’-azobis-2,4-dimethyl valeronitrile (AMVN), air (oxygen), UV and 
oxidizing agents such tert-butyl hydroperoxide (tBHP) and H2O2. 2) Substrates that are the 
targets of ROS, i.e. cholesterol, fatty acids such as linoleic acid, fluorescent probe such as 
fluorescein, LDL and cells cultured in vitro. The degree of oxidative damage to the substrates 
prevented by the test compound is usually determined directly or indirectly through the decrease 
of substrates (i.e. fluorescence decay and cell viability) or the increase of oxidized products (i.e. 
oxidized cholesterol, oxidized linoleic acid, lipid peroxidation intermediates such as 
  
thiobarbituric acid reactive substances (TBA-RS) and conjugated dienes). 3) detection methods 
to allow monitoring the action such as HPLC for lipid hydroperoxides, spectrometer, 
spectrofluorometer and cell viability assays.  
The antioxidant activity of γ-oryzanol has been evaluated in a few models using 
chemicals to induce oxidation and measuring the generation of oxidized products. One of them is 
a cholesterol oxidation model accelerated by AAPH, which was established to compare the 
inhibitory capability of γ-oryzanol and vitamin E on production of oxidized cholesterol (Xu and 
Godber, 2001). The antioxidant activity was determined in terms of the degree to which the 
generation of seven oxidized cholesterol products (7-α- and -β-hydroperoxycholesterol, 5,6-α- 
and -β-epoxycholesterol, 7-α- and -β-hydroxycholesterol and 7-ketocholesterol) was prevented 
in the presence of three major components of γ-oryzanol (cycloartenyl ferulate, 24-methylene 
cycloartanyl ferulate and campesteryl ferulate) or vitamin E components (α-tocopherol, γ-
tocopherol, α-tocotrienol, γ-tocotrienol). The results suggested that 24-methylene cycloartanyl 
ferulate had the highest antioxidant activity and all three major components of γ-oryzanol had 
higher antioxidant activity than vitamin E components. 
Another assessment of antioxidant activity of γ-oryzanol using AAPH as a peroxyl 
radical generator utilized an oxygen radical absorbance capacity assay (Huang et al., 2002). This 
assay used cyclic (α-1,4)-linked oligosaccharides of α-D-gluco-pyranose, which have both 
hydrophilic and hydrophobic regions, to prepare lipophilic antioxidants such as vitamin E 
isomers and γ-oryzanol, and fluorescein as a target of free radical attack. Antioxidant activity 
was determined as the degree to which the fluorescence decay of fluorescein caused by AAPH 
was inhibited over time. Similarly, their results showed that γ-oryzanol possessed the greatest 
antioxidant activity compared to other antioxidants tested including α-tocopherol, γ-tocopherol, 
  
δ-tocopherol and tocotrienols, while α-tocopherol acetate had zero effect. It seemed that γ-
oryzanol had the greatest antioxidant activity towards peroxyl radicals generated by AAPH and it 
was proposed that the antioxidant mechanism of γ-oryzanol might be due to its intramolecular 
hydrogen-bonded methoxyphenols, where hydrogen donation would occur more readily.  
It has also been postulated that the phenol group is the key functional group for 
antioxidant activity and that steric hindrance around the phenol group decreases antioxidant 
activity. For example, in their model of the antioxidant activity of tocopherols, Huang et al. 
(2002) found that relative order of antioxidant activity was α< γ< δ and the reason was explained 
relative to the number of methyl groups ortho to the phenol group where α has two, γ has one 
and δ has zero (see Figure 2.7 for vitamin E structure). The theory has also been approached in a 
review of the antioxidant chemistry of ferulic acid (Graf, 1992). It was explained that the 
antioxidant activity of ferulic acid is due to its phenolic hydroxyl group that has hydrogen 
donating property to scavenge a reactive radical and form a phenoxy radical. This radical is then 
stabilized resonantly because the unpaired electron can be delocalized across the entire molecule 
(Figure 2.8). The second phenolic hydroxyl group can enhance the radical-scavenging property 
by providing additional resonance stabilization and form quinone. The methoxyl group of ferulic 
acid partially destabilizes the phenoxy radical and impairs its antioxidant activity.  
However, in a study using ABTS•+ as a radical generator to study the antioxidant 
activities of benzoic acid or cinnamic acid as a parent acid and other acids (i.e. ferulic acid) with 
hydroxyl groups and methoxyl groups at different positions, the results conflicted with the 
proposed antioxidant mechanism  (Miller and Rice-Evans, 1997). Their results showed that 
vanillic acid (3-methoxy-4-hydroxy benzoic acid) had a higher antioxidant activity than 4-
hydroxy benzoic acid (Figure 2.9 for chemical structures). Two hydroxyl groups attached to 
Position of methyl group     Tocopherols           Tocotrienols
5,7,8-Trimethyl   α-T                        α-T3
5,8-Dimethyl                     β-T                        β-T3
7,8- Dimethyl                  γ-T                         γ-T3 
8-Monomethyl                 δ-T                         δ-T3



































































































































benzoic acid had higher antioxidant activity than one hydroxyl group but did not necessarily 
have higher antioxidant activity than vanillic acid. On the other hand, ferulic acid (3-methoxy-4-
hydroxy cinnamic acid) did not have higher antioxidant activity than 4-hydroxy cinnamic acid 
but had higher antioxidant activity than caffeic acid (3,4-dihydroxy cinnamic acid). Therefore, it 
is difficult, with the available evidence, to postulate the relationship between antioxidant activity 
and structure and to explain whether or not ferulic acid esterified with sterols or triterpenes (γ-
oryzanol) would have a higher antioxidant activity. 
Antioxidant activity of the three major components of γ-oryzanol was also approached in 
a linoleic acid model (Xu and Godber, 2001). Antioxidant activity was determined as the degree 
of inhibition on hydroperoxide formation that resulted from linoleic acid incubated with air flow 
at 37oC for 40 to 200 minutes. There were four hydroperoxide isomers, 9-hydroperoxy-10-
trans,12-cis-octadecadienoic acid [9HPODE(t,c)], [9HPODE(t,t)], [13HPODE(c,t)] and 
[13HPODE(t,t)] measured by normal-phase HPLC and UV detection. The results showed that γ-
oryzanol incubated with linoleic acid at molar ratios of 1:100 and 1:250 significantly decreased 
the formation of hydroperoxides, especially trans,cis and cis,trans forms, which was similar to 
the antioxidant activity of ferulic acid. α-Tocopherol was also tested and showed significant 
antioxidant activity but it was more effective in preventing the formation of trans,trans 
hydroperoxides, which may indicate a different antioxidant mechanism from that of γ-oryzanol 
or ferulic acid. It has been reported that the hydroxyl group in the phenolic ring of ferulic acid 
may be responsible for the antioxidant activity. In this case, ferulic acid presented a higher 
antioxidant activity than γ-oryzanol, especially at a lower concentration. While γ-oryzanol also 
has ferulic acid in its structure, it may suggest that the sterol or triterpene alcohol portion of the 
  
γ-oryzanol structure may affect the antioxidant activity by reducing the mobility because of the 
much larger molecular structure. 
In spite of the efforts contributed by these researchers in studies of γ-oryzanol antioxidant 
activity, the functionality of γ-oryzanol as an antioxidant in the human body has not been 
delineated. One of the objectives of this study, therefore, was to develop a cell culture model in 
vitro as a closer approach to the human body and use it to compare the antioxidant activity of γ-
oryzanol and its three major components to α-tocopherol. The cell line used to develop the cell 
culture model was SVEC4-10, a mouse endothelial cell line derived by SV40 (strain 4A) 
transformation of endothelial cells from axillary lymph node vessels. The oxidizing agent was 
tert-hydroperoxide. The MTT, [3-(4,5-dimethylthiazol-yl)-2-5-diphenyltetrazolium bromide, 
assay was chosen to measure cellular mitochondrial activity as an index of cell viability. Lipid 
peroxidation was also analyzed to detect TBA-RS and conjugated diene formation. Thus, the 
antioxidant activity of γ-oryzanol was determined as the degree to which γ-oryzanol preserved 
cellular mitochondrial activity and prevented lipid peroxidation from tBHP oxidative damage.  
2.9.2 Hypocholesterolemic Capacity 
A hypocholesterolemic effect of different vegetable oils blended with rice bran oil was 
found in healthy young women fed for 7 days (Suzuki and Osima, 1970). This effect was also 
reported in rats fed a normal diet containing 7% rice bran oil or a high cholesterol diet containing 
1% cholesterol and 7% rice bran oil for 4-7weeks and there was also significantly decreased 
levels of serum and liver total cholesterol and LDL and a slightly increased level of HDL in both 
the normal diet and the high cholesterol diet (Sunitha et al., 1997).  
It was also discovered that the unsaponifiable fractions in rice bran oil had cholesterol-
lowering potential (Kiribuchi et al., 1983, and Ikeda et al., 1985). It was found that rats fed a 
  
cholesterol-enriched (0.5%) diet with 0.05-1% of cycloartenol, 24-methylene cycloartanol and/or 
β-sitosterol greatly reduced plasma cholesterol and enhanced cholesterol fecal excretion. 
Later, γ-oryzanol was found to be responsible for the effect (Seetharamaiah and 
Chandrasekhara, 1989). The rice bran oil (10%) diet showed markedly lower serum and liver 
total cholesterol levels in rats and rice bran oil spiked with γ-oryzanol (0.5%) reduced it even 
more significantly. This was also confirmed by Rong et al. (1997) in hamsters fed a diet 
containing 0.1% cholesterol with or without 1% γ-oryzanol for 7 weeks. The γ-oryzanol-fed 
animals had 28% reduction in plasma total cholesterol and 34% reduction of combined LDL and 
VLDL, as well as 25% decrease in cholesterol absorption. Moreover, γ-oryzanol showed no 
effect on endogenous cholesterol synthesis, as measured by the liver and intestinal HMG-CoA 
reductase activities, which is an important indication that the decreased cholesterol level in 
plasma may have resulted from lower cholesterol absorption and that cholesterol synthesis by 
HMG-CoA reductase may not increase to adjust the cholesterol level in response to the 
decreased cholesterol uptake. 
There are only a few γ-oryzanol studies on humans. Sasaki et al. (1990) studied the 
effects of γ-oryzanol on serum lipids of twenty chronic schizophrenic patients with dyslipidemia. 
Each patient was given 100mg of γ-oryzanol three times daily for 16 weeks. The results showed 
that total cholesterol and LDL levels decreased significantly with no side effects recorded, 
suggesting that γ-oryzanol is safe and effective in the treatment of dyslipidemia. 
Since hypercholesterolemia is often a risk factor for many heart diseases associated with 
platelet aggregation and atherosclerosis, the cholesterol-lowering potential of γ-oryzanol may 
also play important roles in preventing these diseases. The γ-oryzanol effect to reduce early 
atherosclerosis was also observed in hamsters fed a diet containing 0.05% cholesterol and 10% 
  
coconut oil with or without 0.5% γ-oryzanol (Rong et al., 1997). The results showed that the 
aortic fatty streak formation, as determined by the degree of accumulation of macrophage-
derived foam cells, was reduced 67%. In addition, the influence of γ-oryzanol on platelet 
aggregation induced by ADP and collagen was also reported in rats fed a 1% cholesterol diet 
containing γ-oryzanol (Seetharamaiah et al., 1990). The platelet aggregation in platelet rich 
plasma induced by both ADP and collagen was significantly inhibited in γ-oryzanol-treated rats. 
In summary, γ-oryzanol has shown promising hypocholesterolemic capacity. To postulate 
the hypocholesterolemic mechanism of γ-oryzanol, the cholesterol absorption and transport in 
humans must be discussed. The cholesterol in the human body comes from two sources. One is 
endogenous cholesterol, which is synthesized in the liver. Some may go into VLDL and be 
secreted into the blood and some are converted to bile salts, stored in the gallbladder, released 
into the duodenum as biological detergents to form micelles with dietary lipids, reabsorbed at the 
ileum and return to the liver through the hepatic portal vein. The other source is exogenous 
dietary cholesterol, which is incorporated into micelles, absorbed at the jejunum and travels to 
the liver through the lymphatic system and bloodstream. During any one day, the cholesterol in 
the intestinal lumen is typically two-thirds from endogenous sources and one-third from dietary 
sources. Cholesterol absorption in humans can vary widely (15 to 75%) (Grundy, 1983). It has 
been demonstrated that decreased serum cholesterol, specifically LDL, can result from the 
inhibition of cholesterol absorption (Gylling and Miettinen, 1995). According to this mechanism, 
drugs such as questran and cholestyramine, which are powdered resins that increase excretion of 
bile salts have been prescribed by doctors for hypercholesterolemic patients.  
Due to the rising controversial issue about using laboratory animals, cell culture models 
have been used for many cholesterol uptake and cholesterol synthesis research projects. Since γ-
  
oryzanol digestibility is unclear, whether or not γ-oryzanol can be absorbed and function in the 
human body i.e. inhibition of cholesterol synthesis in liver is beyond the scope of this study. This 
study focused on the γ-oryzanol effects on the availability of cholesterol for uptake into in vitro 
human intestinal cells, especially the effects on micellar solubility of cholesterol (free and ester 
forms) and on inhibition of cholesterol esterase to hydrolyze cholesteryl esters.   
2.10 Applications of γ-Oryzanol 
Since the functionality of γ-oryzanol has been found to be promising, rice bran or γ-
oryzanol may have great market potential and be applied to a wide range of products. It can be 
enriched in food products such as cereal and margarine for its cholesterol-lowering and 
antioxidant effects, put into frying oil for its stability and into food coating or packaging material 
for antioxidant potential to extend shelf life. It can also be supplemented into non-food products 
such as sun protection skin lotion due to UV absorption and skin-care products for repairing dry 




CHAPTER 3. ANTIOXIDANT ACTIVITY EXPERIMENTS USING  
AN IN VITRO MOUSE LYMPH AXILLARY ENDOTHELIAL CELL MODEL 
 
3.1 Introduction 
The potential antioxidant activity of γ-oryzanol has been studied in chemical models such 
as in a cholesterol model to reduce cholesterol oxidation accelerated by 2,2-azobis(2-
methylpropionamidine) dihydrochloride (Xu et al., 2001) and in a linoleic acid model to prevent 
linoleic acid oxidation induced by air (Xu and Godber, 2001). The antioxidant activity of ferulic 
acid, part of γ-oryzanol structure, has also been investigated as determined by its ability to 
scavenge ABTS•+ radical cation more effectively than vitamin C (Miller and Rice-Evans, 1997) 
and to inhibit lipid peroxidation (malondialdehyde production) in rat brain homogenates in vitro 
(Sharma, 1976). However, the functionality of γ-oryzanol as an antioxidant in the human body 
has not been delineated. The objectives of this study, therefore, were to develop an in vitro cell 
model assay as an approach that more closely reflects what might occur in the human body and 
use it to evaluate the effect of γ-oryzanol. The latter could be distinguished by testing its ability 
to preserve cellular mitochondrial activity from damage caused by tert-hydroperoxide (tBHP) 
compared with the effect of α-tocopherol. The antioxidant activity of the three major 
components of γ-oryzanol and the possible synergism among γ-oryzanol, ferulic acid and α-
tocopherol were also studied.   
3.2 Materials and Methods 
3.2.1 Materials and Reagents 
Milled rice bran was obtained from Riviana Rice Mill, Abbeville, LA. Distilled and 
deionized water was used to prepare culture media and solutions. Ferulic acid, α-tocopherol, 
lecithin, fatty acid free bovine serum albumin, MTT assay kit, LDH test kit, Bradford reagent, 
  
Hanks balanced salts, thiobarbituric acid, butylated hydroxytoluene and trypan blue solution 
were purchased from Sigma Chemical Co., St. Louis, MO. Sodium bicarbonate and HCl were 
purchased from Mallinckrodt, Inc., Paris, KY. All the solvents used were HPLC grade. Methanol 
hexane, dichloromethane, acetonitrile, acetic acid and trichloroacetic acid were purchased from 
Fisher Scientific, Fair Lawn, NJ. Ethanol was USP absolute 200 proof purchased from AAPER 
Alcohol and Chemical Co., Shelbyville, KY. Culture plates, flasks and scrapers were purchased 
from Corning Inc., Corning, NY, and the sterile disposable syringe filter was 0.2µm PES 
purchased from Whatman, Clifton, NJ. 
3.2.2 Extraction of γ-Oryzanol from Rice Bran and Chemical Analysis of γ-Oryzanol, Ferulic 
Acid and α-Tocopherol  
Solvent extraction of rice bran was done to obtain crude rice bran oil. Two hundred 
grams of milled rice bran were mixed with hexane and then filtered and the hexane extraction 
was repeated for a total of 3 times. The hexane layer was combined into a round-bottom bottle, 
followed by vacuum evaporation (45oC, CentriVap Console, Labconco Inc., Kansas City, MO) 
to remove hexane and yield crude oil. To separate γ-oryzanol from the oil, a preparative normal-
phase high performance liquid chromatography (HPLC) procedure developed by Xu and Godber 
(1999) was used. The preparative HPLC system consisted of a Waters (Milford, MA) Prepak® 
RCM base connected with two cartridges (each 25mm×10cm Prep Nova-Pak HR silica with 
particle size 6µm) and a Guard-Pak insert, a U6K manual injector, a 510 pump and a Lambda-
Max 481 LC Spectrophotometer (wavelength 330 nm). Mobile phase was methanol with a 
constant flow rate at 15 mL/min and 2mL of the crude oil were injected each time. The eluate 
containing γ-oryzanol was collected (25-30min) and the solvent was evaporated using a vacuum 
evaporator.  
  
To separate γ-oryzanol fractions, the HPLC system used consisted of a pump (Waters 510 
HPLC Pump), an autosampler (Waters 715 Sample Processor), a column (C18, MICROSORB-
MV 100 Å, Varian) and a UV detector (Waters 486 Tunable Absorbance Detector) at wavelength 
330 nm. The mobile phase was methanol, acetonitrile, dichloromethane and acetic acid 
(50:44:3:3) and the flow rate was 1.4 mL/min. The γ-oryzanol obtained from rice bran oil was 
dissolved in the mobile phase. Ultrasonication was used to help dissolve when necessary. One 
hundred µL of γ-oryzanol solution (1.5mg/mL) was injected each time. Cycloartenyl ferulate, 
24-methylene cycloartanyl ferulate and campesteryl ferulate were collected (at retention time 
5.2-5.8, 5.8-6.3 and 6.3-6.8 minutes, respectively), dried using a vacuum evaporator, sealed with 
foil and kept frozen until further experiments.  
Determination of γ-oryzanol, ferulic acid and α-tocopherol concentrations was obtained 
from retention time comparison and quantifications of known standards. The HPLC system to 
analyze α-tocopherol was the same as for γ-oryzanol except that the detector was a Waters 470 
Scanning Fluorescence Detector with excitation wavelength set at 290nm and emission at 
330nm.  
3.2.3 Emulsion Preparation 
Because γ-oryzanol and α-tocopherol are hydrophobic, emulsifiers such as lecithin and 
bovine serum albumin (BSA) were needed to prepare γ-oryzanol and α-tocopherol in aqueous 
culture solutions. γ-Oryzanol, α-tocopherol or ferulic acid was dissolved in ethanol (50mM) and 
filtered through 0.2µm filter for sterilization and the concentration was checked by HPLC. Each 
was then diluted to make 2mM stock solution in filtered Hanks balanced salt solution (HBSS)-
emulsion composed of lecithin and essential fatty acid free BSA, whose concentrations were 
  
tested first to assess impact on cell viability. The emulsion was then evaluated to be free of 
precipitation. For cell culture experiments, the final ethanol concentration did not exceed 2%. 
3.2.4 Cell Culture 
 For antioxidant activity experiments, mouse lymph axillary endothelial cell line, 
SVEC4-10 (ATCC CRL-2181), was chosen. The cells were grown in Dulbeccos modified 
Eagles medium (DMEM) with 4mM L-glutamine, 4.5g/L glucose, 1.5g/L sodium bicarbonate, 
15mM N-[2-hydroxyethyl] piperazine-N-[2-ethanesulfonic acid] (HEPES) and 10% fetal bovine 
serum in a 37oC 5% CO2 humidified incubator. To maintain the cell line, cells were detached 
from surface using 0.25% trypsin solution and split to new 25-cm2 culture flasks (1:5-1:7 split 
ratio). Cells reached confluency to form a monolayer in about 3-4 days. 
Cells for antioxidation experiments were cultured in 96-well (12x8) cell culture plates. 
After subculture as described above, cell suspension was diluted in new medium to at least 105 
cells/mL and 100µL of the diluted cell suspension was transferred to each well. If not all 96 
wells were used, only the middle wells of the plate would be used to prevent edging effect due 
to uneven evaporation and the unused wells were filled with water to maintain humidity. An 
exact cell counting was performed at this time (as described below). The plates were kept at 
37oC in the humid incubator until they reached confluency (about 3-4 days) for further 
experiments. 
3.2.4.1 Growth Curve 
After obtaining a cell line, it is recommended to construct a growth curve in order to help 
understand the cell growth characteristics. Cell counting using dye such as trypan blue and the 
hemacytometer is one of the commonly used methods. For adhesive cell lines including the one 
used in this project, after trypsinization, 200µL of cell suspension to be counted was mixed with 
  
200µL 0.4% trypan blue solution. Pipetting up and down at least 20 times was done to break the 
cell clumps. A drop of the cell suspension was placed to the edge of one side of the 
hemacytometer covered with the coverslip and repeated for the other side. The cell suspension 
was drawn by the force of capillary action. The hemacytometer was then transferred to the 
microscope with a standard 10x objective. The counting chamber of the hemacytometer 
consisted of nine squares and each square had the volume of 10-4mL (1-mm long × 1-mm wide × 
0.1mm deep). For cell viability, only the sort of healthy to viable cells, which were 
impermeable to trypan blue and appeared clear, were counted, as opposed to sick cells, which 
could not exclude dye and appeared dark. At least 100 cells per square were counted. Cell count 
was calculated as viable cell numbers per mL, which was the average cell number counted in one 
square times 104 and times 2 with 1:1 trypan dilution. Cell counting was done everyday for 6 
days after subculture. The SVEC4-10 cell growth curve from subculture was expressed as cell 
count in logarithmic scale versus days. 
3.2.4.2 MTT and LDH Assays for Cell Viability 
To measure cell viability under oxidative stress, an MTT assay kit was used to measure 
the activity of mitochondrial dehydrogenases in living cells. After the test solution was removed 
and the cells were washed three times with HBSS, 40µL of 1.25mg/mL MTT in HBSS, which is 
yellow color, was added to cells. After incubation at 37oC in the dark for 2 hours, the 
mitochondrial dehydrogenases of viable cells cleaved the tetrazolium ring and yielded purple 
formazan crystals, which are insoluble in aqueous solution. Then 100µL/well of MTT 
solubilization solution containing 10% Triton X-100 plus 0.1N HCl in anhydrous isopropanol 
was added to solubilize purple formazan crystals. Pipetting up and down at least 100 times 
helped solubilization in dense culture situation. Absorbances at 570nm for color development 
  
and at 690nm for background were read using a microplate spectrophotometer (SPECTRAmax® 
PLUS, Molecular Devices Co., Sunnyvale, CA). An increase or decrease of cell numbers after 
exposure to a test solution would correspond to a concomitant change in the amount of purple 
formazan formed or in the optical density at absorbance 570nm. The cell viability under 
exposure to a test compound was expressed in %cellular mitochondrial activity, which was the 
ratio of absorbance reading difference between 570nm and 690nm of test compound (A570 − 
A690) to that of control (Ao570  Ao690): 
                         A570 − A690 
%Cellular mitochondrial activity  =    × 100% 
                             Ao570  Ao690   
The lactate dehydrogenase (LDH) assay was another method used to evaluate cell 
viability in terms of the degree of cell membrane integrity. It was used to detect LDH released 
from both surviving and dead cells. To measure LDH released from damaged cells, 50µL/well of 
the cell supernatant to be measured was transferred to a new plate and mixed with 25µL/well of a 
freshly prepared LDH assay solution containing dye, along with substrate and enzyme (1:1:1). 
To measure LDH in surviving cells, the cells were washed with HBSS three times to remove test 
solution and a cell lysis solution (1% sodium dodecyl sulfate (SDS) in culture grade water) at 
100µL/well was applied to cells for 45 minutes, followed by 50µL/well LDH assay mixture as 
described above. After incubation at room temperature in the dark for 30 minutes, absorbances at 
490nm for color development and at 690nm for background were read using a 
spectrophotometric plate reader. 
3.2.5 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol Emulsion 
Since the compounds of interest were prepared in ethanol and diluted in HBSS-emulsion 
containing emulsifiers, lecithin and BSA, each one was tested for cytotoxicity. After incubation 
  
in any situation, the test emulsions were removed and discarded and cells were gently washed 
with HBSS 3 times. MTT tests were then performed to monitor cell viability. The highest 
concentrations of each test compound without cytotoxicity would be used to study its antioxidant 
activity. 
3.2.5.1 Cytotoxicity Studies of Emulsifiers, Lecithin and BSA 
First, the cytotoxicity of emulsifiers such as lecithin and BSA that were needed to 
dissolve hydrophobic compounds in aqueous solution was studied. To determine the 
concentration of lecithin and BSA that could be used to prepare emulsion without affecting cell 
viability, 50µL/well of each lecithin×BSA combination was added to confluent cells and 
followed by 50µL/well HBSS. Final concentration of lecithin at 0, 0.05, 0.10, 0.15, 0.20 and 
0.25mM and essential fatty acid free BSA at 0, 1, 3, 5, 7 and 9mg/mL were prepared in HBSS in 
a 6x6 factorial design. The cells were incubated at 37oC with a humidifier tray filled with water 
for 4.5 hours, followed by cell washing and MTT assay for cell viability compared to the control 
(HBSS). 
3.2.5.2 Cytotoxicity Studies of 2% Ethanol in Lecithin×BSA HBSS-Emulsion  
Since ethanol was required to dissolve γ-oryzanol or α-tocopherol, the cytotoxicity of 2% 
ethanol, which was the final concentration after diluting in HBSS-emulsion containing lecithin 
and BSA, was also considered. After SVEC4-10 cells reached confluency, 100µL of 2% ethanol 
in HBSS-emulsion, containing 0.25mM lecithin and 5mg/mL BSA determined previously, was 
incubated with cells at 37oC for 4 or 22 hours, followed by cell washing and MTT assay, along 
with HBSS or HBSS-emulsion without ethanol for comparison. 
  
3.2.5.3 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol 
The purpose was to determine the maximum concentration of γ-oryzanol, ferulic acid and 
α-tocopherol without affecting cell viability prior to the antioxidant activity studies. γ-Oryzanol, 
α-tocopherol or ferulic acid emulsion (2% ethanol, 0.25mM lecithin and 5mg/mL BSA in HBSS) 
in a serial array of concentrations up to 1.0mM was added to confluent SVEC4-10 cells 
(100µL/well) for 4 or 23 hours at 37oC. The cytotoxicity of three major components of γ-
oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate was 
also tested. Each one was incubated with confluent cells for 1 hour at concentrations up to 1mM 
and for 22 hours at concentrations up to 0.50mM. 
3.2.5.4 Cytotoxicity Studies of Interactions among γ-Oryzanol, Ferulic Acid and α-
Tocopherol 
For possible synergistic effects among γ-oryzanol, ferulic acid and α-tocopherol, an 
additional set of cytotoxicity experiments for combinations was also tested. Each combination 
was incubated with cells (100µL/well) at concentrations of 0.5mM γ-oryzanol+0.5mM α-
tocopherol, 0.5mM γ-oryzanol+0.3mM ferulic acid, 0.5mM α-tocopherol+0.3mM ferulic acid or 
0.25mM γ-oryzanol+0.25mM α-tocopherol+0.2mM ferulic acid for 1 hour at 37oC or at total 
concentrations up to 0.50mM of γ-oryzanol+α-tocopherol, γ-oryzanol+ferulic acid, α-
tocopherol+ferulic acid or γ-oryzanol+α-tocopherol+ferulic acid for 22 hours. 
3.2.6 Oxidative Stress by tert-Butyl Hydroperoxide 
The oxidation agent tBHP was used to cause oxidative stress in cells and the tBHP 
oxidation conditions for antioxidant activity experiments depended on how long the test 
emulsion was incubated with cells. Without preincubation with test solution for 22 hours, cells 
were simultaneously incubated with 50µL/well of HBSS-emulsion that would be used to prepare 
  
each test compound (4% ethanol, 0.50mM lecithin and 10mg/mL BSA in HBSS) and 50µL/well 
of tBHP in a final concentration of 0, 8, 12, 16 or 20mM in HBSS for 0, 15, 30, 45 or 60 minutes 
at 37oC.  
If preincubated with 100µL/well of 2% ethanol HBSS-emulsion, which would contain 
each test compound later for antioxidant activity studies, for 22 hours at 37oC, after cell washing 
with HBSS 3 times, cells would then be incubated with tBHP at concentrations of 0, 4, 8 or 
12mM in HBSS for 0, 15, 30, 45, 60 minutes at 37oC. After the oxidation time in both 
conditions, the cells were gently washed with HBSS 3 times and placed in HBSS until the 
longest incubation time was concluded and ready for MTT tests, i.e. 0 oxidation time means 
tBHP was added and removed immediately, washed and replaced by HBSS for 60 minutes and 
15 minutes of oxidation means 15 minutes in tBHP plus 45 minutes in HBSS and so on. The 
tBHP concentration that could cause significant cell death would be used for antioxidant activity 
studies. 
3.2.7 Studies of Antioxidant Activity and Synergism of γ-Oryzanol, Ferulic Acid and α-
Tocopherol 
Antioxidant activity, in terms of the degree of tBHP oxidative damage on mitochondria in 
SVEC4-10 cells that any test compound would reduce, was expressed as %cellular mitochondrial 
activity (the percentage of tBHP/HBSS of each test solution at a certain oxidation time compared 
to that at 0 oxidation time or at a certain concentration compared to the control emulsion). All 
experiments were conducted on confluent cells and after oxidation in any conditions, the cells 
would be gently washed with HBSS three times, followed by the MTT assay to monitor cell 
viability. The antioxidant activity of γ-oryzanol and ferulic acid, compared to α-tocopherol, 
along with the three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene 
cycloartanyl ferulate and campesteryl ferulate, and the synergistic effect among γ-oryzanol, 
  
ferulic acid and α-tocopherol were studied. The interferences of γ-oryzanol, α-tocopherol or 
ferulic acid with tBHP or MTT were also tested. 
3.2.7.1 Oxidation Time Effect on Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-
Tocopherol 
There were four conditions designed to approach the antioxidant activity. For 
simultaneous presence of the test compound and tBHP, cells were incubated with 50µL/well of 
each test solution (2.0mM γ-oryzanol or α-tocopherol or 1.2mM ferulic acid) and 50µL/well of 
HBSS or 20mM tBHP for 0, 15, 30, 45 or 60 minutes. For pretreatment of test compound with 
cells before tBHP oxidation, after being preincubated with 100µL/well of each test solution 
(0.50mM γ-oryzanol, α-tocopherol or ferulic acid) for 22 hours at 37oC, cells were 1) washed 
with HBSS three times and followed with 100µL/well of HBSS or 12mM tBHP for 0-60 
minutes, or 2) not washed, continuously accompanied by each test solution, and 20µL/well of 
HBSS or 72mM tBHP (resulting in 12mM in the 120µL/well of mixture) immediately added and 
incubated for 0-60 minutes. For the effect of each test compound on tBHP oxidation before 
introduction to cells, 2.0mM γ-oryzanol or α-tocopherol or 1.2mM ferulic acid was incubated 
with HBSS or 40mM tBHP (1:1) in a 4-mL vial for 22 hours at 37oC and then 100µL of each 
mixture was added to cells for 0-60 minutes.  
3.2.7.2 Antioxidant Activity of The Three Major Components of γ-Oryzanol 
The antioxidant activity of the three major components of γ-oryzanol, cycloartenyl 
ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate, at different concentrations 
was investigated. After reaching confluency, SVEC4-10 cells were preincubated with 
100µL/well of each test solution up to 0.50mM for 22 hours at 37oC, followed by gently washing 
and 100µL/well of HBSS or 12mM tBHP for 1 hour at 37oC.  
  
3.2.7.3 Synergistic Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol 
For simultaneous presence of each test compound with tBHP, cells were incubated with 
50µL/well of each combination of test solution (1.0mM γ-oryzanol+1.0mM α-tocopherol, 
1.0mM γ-oryzanol+0.6mM ferulic acid, 1.0mM α-tocopherol+0.6mM ferulic acid or 0.6mM γ-
oryzanol+0.6mM α-tocopherol+0.4mM ferulic acid) and 50µL/well of HBSS or 20mM tBHP for 
60 minutes. For pretreatment with the test compound, cells were preincubated with 100µL/well 
of each test solution (0.25mM γ-oryzanol+0.25mM α-tocopherol, 0.25mM γ-oryzanol+0.25mM 
ferulic acid, 0.25mM α-tocopherol+0.25mM ferulic acid or 0.20mM γ-oryzanol+0.20mM α-
tocopherol+0.20mM ferulic acid) for 22 hours at 37oC, followed with cell washing and 
100µL/well of HBSS or 12mM tBHP for 60 minutes.  
3.2.8 Lipid Peroxidation and Bradford Protein Assays 
To measure the antioxidant activity against lipid peroxidation, two commonly used 
methods, thiobarbituric acid-reactive substances (TBA-RS) method and conjugated diene 
formation were performed. The TBA-RS method is to measure one of the oxidation intermediate 
products, malonaldehyde, which will react with TBA and gives pink color, as an indicator of 
lipid peroxidation A modified method from McDonald and Hultin (1987) was used. TBA-RS 
reagent was prepared prior to use: TBA (final concentration 0.375%) was first dissolved in 
0.25N HCl with heating and stirring if necessary and then trichloroacetic acid (final 
concentration 15%) was added. SVEC4-10 cells for TBA-RS assay were cultured in 25-cm2 
culture flasks. After reaching confluency, cells were gently washed three times with HBSS and 
followed with preincubation in 8mL of 0.5mM γ-oryzanol, α-tocopherol, ferulic acid, their 
combinations or each of the three major components of γ-oryzanol at 37oC for 22 hours. Each 
test solution was performed independently in a culture flask. After preincubation, the test 
  
solution was removed, and the cells were gently washed three times with HBSS and then treated 
with 8mL of HBSS or 12mM tBHP for 1 hour at 37oC. After incubation, HBSS or tBHP solution 
was removed and the cells were gently washed with HBSS three times and scraped off into 1mL 
of cold deionized water. Each cell suspension was transferred to a 4-mL vial and ultrasonicated 
(Sonic Dismembrator, Fisher Scientific, Fair Lawn, NJ) at output 3 watts for 1 minute to 
homogenize. Each test sample (750µL) or standard 1,1,3,3-tetramethoxypropane (TMP) (0, 0.05 
and 0.10 µg/mL) was transferred to a 15-mL test tube with cap and mixed with 1.5mL of TBA-
RS reagent and 50µL of 2% butylated hydroxytoluene in ethanol. The tubes were boiled for 15 
minutes, cooled in running water for 10 minutes and centrifuged at 2000g for 40 minutes. The 
supernatant was then transferred to acryl cuvettes to read absorbance. First, the absorption 
spectrum was scanned from 350 to 800nm. The wavelength with the highest absorbance was 
adjusted for background by subtracting the wavelength with lowest absorbance, which was then 
used to determine concentration of TBA reactive substances in each test sample. A standard 
curve was generated using TMP. The crude protein concentration in remaining cell suspension 
was tested by a Bradford protein assay. The same experiment of TBA-RS and Bradford protein 
assays was repeated again on a different day. 
The excess TBA reactive substances produced in each sample during oxidation were 
expressed in µg of TMP equivalent per gram of protein in tBHP minus that in HBSS. 
Antioxidant activity of each test solution in terms of the degree of excess TBA reactive 
substances prevented was compared to the control. The lower the excess TBA reactive 
substances generated in a test solution during oxidation, the higher the antioxidant capacity. 
Conjugated diene formation is another index for lipid peroxidation. A method modified 
from Toschi et al (2000) was used. After cells were subcultured in 25-cm2 flasks and had 
  
reached confluency, they were preincubated with 2% ethanol in HBSS-emulsion at 37oC for 22 
hours. The emulsion was then removed and cells were washed with HBSS three times and 
treated with 8mL of HBSS or 12mL tBHP for 1 hour. Cells were again gently washed three times 
with HBSS, scraped off into 1mL of methanol and extracted in chloroform/methanol/H2O (2:1:1) 
three times. The chloroform layers were collected and combined and evaporated under nitrogen 
gas. The residue of each sample was then dissolved in 500µL of acetonitrile and the absorbance 
spectrum from 190 to 250nm was scanned. 
For Bradford assay to measure crude cell protein, two aliquots of 5 to 10µL homogenized 
cell suspension were made into 1/100 to 1/200 dilutions with deionized water and mixed with 
Bradford reagent (1:1) for 5 minutes at room temperature in the dark. Similarly, the spectrum 
from 350 to 800nm was scanned first to choose wavelengths for the maximum absorbance and 
the background. A serial dilution of BSA at 0, 2, 4, 6µg/mL was used to construct a standard 
curve (concentration versus absorbance). The crude protein concentration in each cell sample 
was calculated by converting the absorbance to concentration using the standard curve and 
multiplying by the proper dilution factor.  
3.2.9 Experimental Design and Statistical Analysis 
The experimental design for most of the cytotoxicity or antioxidant activity experiments 
was a strip block design. Each test solution was randomly assigned to the columns of the plate 
while each concentration of the test solution or each oxidation time was randomly assigned to the 
rows of the plates. The replications were done as columns or rows whichever was available. The 
test solution incubated with HBSS and tBHP were done on different plates but in the same 
positions. Whole experiments were replicated on different days with different random 
  
assignments of test solutions and concentration levels or oxidation times. To analyze, proc mix in 
SAS version 8.2 (SAS Institute Inc., Cary, NC) was used (see Appendix I for SAS codes). 
3.3 Results and Discussion 
3.3.1 Emulsion Preparation 
Figure 3.1 shows the HPLC chromatograms of γ-oryzanol, ferulic acid and α-tocopherol. 
The retention time of ferulic acid was 1.5 minutes and γ-oryzanol was 5-9 minutes and the three 
major components, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl 
ferulate were collected at 5.2-5.8, 5.8-6.3 and 6.3-6.8 minutes, respectively. 
High concentration of γ-oryzanol and α-tocopherol stock solution (sterile) in ethanol 
could be stored in a freezer but the concentration increased when evaporation of ethanol 
occurred. Concentrations were tested by HPLC and additional filtered ethanol was added to the 
stock to obtain a concentration of 50mM and the concentrations were assured by HPLC. 
Otherwise, without the addition of ethanol, direct dilution from greater than 50mM stock would 
result in γ-oryzanol and α-tocopherol precipitation. This may imply the importance of ethanol 
acting as both solvent and emulsifier. Therefore, 2mM stock solution for cell culture experiments 
were obtained by diluting 50mM in HBSS-emulsion containing 500µM lecithin and 10mg/mL 
fatty acid free BSA, resulting in 4% ethanol. The stock solution higher than 2mM was difficult to 
prepare because γ-oryzanol higher than 50mM was difficult to dissolve in ethanol and higher 
concentration of emulsifiers, lecithin, BSA or other emulsifiers would be required. The γ-
oryzanol and α-tocopherol emulsions were light milky color but without any suspended particles 
and could be stored in a refrigerator for at least two months without precipitation. 
























































































































































































































































































































































































































































































































































3.3.2 Cell Selection, Cell Viability Assay and Cell Growth Curve 
Besides SVEC4-10 cells, HUV-EC-C, a normal human umbilical vein endothelial cell 
line, and CPA, a normal bovine pulmonary artery endothelial cell line, were also cultured. 
However, both cell lines failed to grow well and required about 2 weeks to reach confluency. 
Thus, the SVEC4-10 cell line, which was available at the time, was used as a model to determine 
antioxidant activity. The SVEC4-10 cell line is an endothelial cell line from axillary lymph node 
vessels. The cells grow efficiently on plastic to a monolayer without the requirement of any other 
exogenous growth factors or matrix components. As for the method to measure cell viability, 
another assay to detect LDH released from injured cells was evaluated; however, the MTT assay 
was chosen because LDH reagent reacted with α-tocopherol and gave false positive and using it 
on SVEC4-10 cells showed low response signals (absorbance less than 0.1) whereas when using 
MTT, the response absorbance could reach as high as 0.6. 
To construct a growth curve, SVEC4-10 cells were seeded starting at 4x105cells/mL and 
counted everyday for 6 days. Unlike a conventional growth curve consisting of a lag phase, 
which is the time needed to recover from subculture and cell number remains the same, the cell 
populations decreased during the next day after subculture (Figure 3.2). This situation commonly 
occurs in some cell lines when cells recover from the stress at the beginning. Then the cell 
populations increased exponentially (day1-4), the log phase, until reaching the plateau phase, in 
which the cells reached confluency to form a monolayer and the cell growth slows down due to 
the limited nutrition and generated wastes (day4-5). However, some tumor cells, as in this case, 
can later accumulated and continue to grow for a few more days. To maintain a cell line, it would 
be preferable for the next passage at the end of the log phase to yield healthy and consistent cell 


















Figure 3.2. Growth curve of SVEC4-10 cells starting at 
4×105 cells/mL after subculture (data shown
were duplicates) 
  
the SVEC4-10 cells were always plated at 4x105cells/mL and used for antioxidant activity 
studies at the 3rd to 4th day, when they had reached confluency. 
3.3.3 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol Emulsion 
3.3.3.1 Cytotoxicity Studies of Emulsifiers and Ethanol 
Results in Figure 3.3 show that, statistically, there was a lecithin concentration main 
effect and a BSA concentration main effect but no interaction between lecithin and BSA. 
However, each concentration of BSA (1, 3, 5 or 7 mg/mL), regardless of the lecithin effect, and 
each concentration of lecithin (0.05, 0.1, 0.15 or 0.2mM), regardless of the BSA effect, were not 
significantly different from the control (HBSS) when incubated with cells for 4.5 hours. There 
was also no significant difference between each of the 36 lecithin and BSA (6×6) combinations 
and the control, including the mixture of 0.25mM lecithin and 5mg/mL BSA in HBSS, which 
was used to prepare the emulsion of γ-oryzanol, α-tocopherol or ferulic acid in the later studies. 
Since ethanol was one of the few solvents that could be used to dissolve γ-oryzanol, α-
tocopherol or ferulic acid and was used for cell culture experiments, the effect of 2% ethanol in 
HBSS emulsion with 0.25mM lecithin and 5mg/mL BSA was studied. The results showed that, 
the cellular mitochondrial activity (93.03%) was not significantly different from the control 
(HBSS) (100%), when 2% ethanol HBSS-emulsion was incubated with SVEC4-10 cells for 4 
hours (Figure 3.4(a)), while it significantly decreased to 77.02% when incubated for 22 hours 
(p<0.05) (Figure 3.4(b)). Even though SVEC4-10 cells were more susceptible to 2% ethanol, it 
was necessary to use ethanol due to the difficulty in dissolving γ-oryzanol and α-tocopherol in 
aqueous culture solution. Therefore, in the further experiments, 2% ethanol in HBSS emulsion 
was always performed and referred to as the control for comparison.  
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Figure 3.3. Cytotoxicity study of emulsifiers, lecithin and fatty acid






















Figure 3.4. Cytotoxicity studies of 2% ethanol in HBSS-emulsion 
incubated with SVEC4-10 cells for (a) 4 and (b) 22 hours. 









3.3.3.2 Cytotoxicity Studies of γ-Oryzanol, Ferulic Acid and α-Tocopherol 
First of all, the results did not show any false positives between γ-oryzanol, ferulic acid or 
α-tocopherol and MTT reagent, which means γ-oryzanol, ferulic acid or α-tocopherol if present 
would not interfere with the MTT assay. The cytotoxicity results showed that when incubated 
with SVEC4-10 cells for four hours, the effects of γ-oryzanol, ferulic acid and α-tocopherol on 
cellular mitochondrial activity were not all the same when averaged out for concentration effect 
(Figure 3.5(a)). γ-Oryzanol and α-tocopherol concentrations up to 1.0mM did not decrease 
cellular mitochondrial activity significantly while ferulic acid at 0.8 and 1.0mM did (p<0.05). 
Therefore, the highest concentrations of γ-oryzanol and α-tocopherol studied for their 
antioxidant activity would not exceed 1.0mM and 0.6mM for ferulic acid. 
The results in Figure 3.5(b) showed that when incubated with cells for 22 hours, γ-
oryzanol, ferulic acid and α-tocopherol up to 1.0mM did not decrease cell viability significantly. 
There was no concentration effect when averaged out for the effect of the type of test compound. 
However, to be conservative due to the fact that the overnight preincubation may be a stress to 
cells, 0.5mM was the highest concentration of γ-oryzanol, ferulic acid or α-tocopherol tested for 
their antioxidant activity.  
Additionally, since the three major components of γ-oryzanol make up about 70-80% of 
total γ-oryzanol, the cytotoxicity of the three pure compounds was also tested. Each of the 
components up to 1.0mM was incubated with cells for 1 hour and up to 0.5mM for 22 hours. The 
results showed that incubation time of 1 hour did not significantly decrease %cellular 
mitochondrial activity (Figure 3.6(a)) and up to 1.0mM of each compound incubated with cells 
for 1 hour would later be studied for antioxidant activity. The results also showed that the 
























Figure 3.5. Cytotoxicity study of γ-oryzanol, ferulic acid and 
α-tocopherol incubated with SVEC4-10 cells for 




















































Figure 3.6. Cytotoxicity studies of the three major components of 





























24-methylene cycloartanyl ferulate 
campesteryl ferulate 
  
(Figure 3.6(b)). Therefore, 0.5mM of each component would be the highest concentration 
studied for their antioxidant activity, except that 0.25mM was used for campesteryl ferulate, if 
incubated with cells for 22 hours. 
3.3.3.3 Cytotoxicity Studies of Interactions among γ-Oryzanol, Ferulic Acid and α-
Tocopherol 
The cytotoxicity of 0.50mM γ-oryzanol+0.50mM α-tocopherol, 0.50mM γ-
oryzanol+0.30mM ferulic acid, 0.50mM α-tocopherol+0.30mM ferulic acid or 0.25mM γ-
oryzanol+0.25mM α-tocopherol+0.20mM ferulic acid incubated with cells for 1 hour was 
studied and the result showed that no combinations diminished cell viability differently from the 
control (2% ethanol HBSS-emulsion) (Figure 3.7(a)). There was no effect of concentration levels 
regardless of type of test solution. Thus, the synergistic antioxidant activity among these test 
compounds at these concentration levels under this condition would be evaluated. 
When incubated with cells for 22 hours, however, the results showed that γ-
oryzanol+ferulic acid and α-tocopherol+ferulic acid at all concentrations significantly decreased 
cell growth compared to the control (Figure 3.7(b)). Therefore, only the synergistic antioxidant 
activity of γ-oryzanol+α-tocopherol would be further studied.  
3.3.4 The Effects of tBHP Concentration and Oxidation Time on SVEC4-10 Cellular 
Mitochondrial Activity 
When cells were not preincubated with 2% ethanol HBSS-emulsion, statistically there 
were effects due to tBHP concentration, oxidation time and also concentration and time 
dependent interactions (Figure 3.8(a)). Regardless of the incubation time, 20mM of tBHP caused 
greater reduction in cellular mitochondrial activity than that caused by other levels of tBHP. 
Regardless of the concentration effect, oxidation for 60 minutes resulted in the greatest reduction 
























Figure 3.7. Cytotoxicity studies of interaction among γ-oryzanol, ferulic 
acid and α-tocopherol incubated with SVEC4-10 cells for 














































































0 15min 30min 45min 60min
Figure 3.8. tBHP oxidation (0-60min) on SVEC4-10 cells (a) and 
(b) after preincubated with 2% ethanol HBSS-emulsion 
for 22 hours
  
minutes could significantly reduce cell viability compared to the control (p<0.05), but only 
20mM injured cells significantly compared to any concentration level at any incubation time 
level. Thus, for further antioxidant activity experiments, tBHP oxidation conditions for SVEC4-
10 cells without preincubation would be 20mM for 60 minutes.  
For SVEC4-10 cells preincubated with test emulsions overnight, the oxidation conditions 
varied. Less oxidation for preincubated cells was needed to induce the same amount of cell 
injury. The results (Figure 3.8(b)) indicated that statistically there was no tBHP concentration 
effect, which indicates that with the oxidation time effect averaged out, there was no significant 
differences among any concentration level. However, overall there was an oxidation time effect 
(15-60 minutes in tBHP, regardless of concentration, significantly impaired cell viability 
compared to the control (HBSS) (p<0.05)). There was also an interaction effect between 
concentration and time (p<0.05). A tBHP concentration of 12mM at oxidation time of 60 
minutes decreased cellular mitochondrial activity to a greater extent compared to any 
concentration level (p<0.05) but not at any time shorter than 45 minutes. Therefore, 12mM tBHP 
for 60 minutes was used later to study antioxidant activities of γ-oryzanol, ferulic acid and the 
three major components of γ-oryzanol compared to α-tocopherol which were preincubated with 
cells overnight. 
There was an interesting characteristic of SVEC4-10 cell growth: when comparing the 
two formats (preincubation or not), cells seemed to revive more completely in response to 
oxidative stress after preincubation. Without oxidative stress, the cells grew significantly over 
time, which may mean that SVEC4-10 cells had a rapid metabolism, especially after 
preincubation with HBSS-emulsion. It has been reported that tBHP at very low concentration 
(10-5mM) could actually stimulate cell growth on polyoma virus transformed baby hamster 
  
fibroblasts and corresponding non-transformed cells (Burdon and Gill, 1989). The reason may be 
relevant to the inflammatory response to tissue replenishment following tissue damage due to 
oxidative stress. However, the tBHP concentrations used here to induce oxidative damage were 
much higher. More research is needed to further understand the mechanism of tBHP 
cytotoxicity. These results also provided another reason to always do HBSS experiments, in 
addition to tBHP, in order to compare tBHP/HBSS ratio to that of the control at 0 time.  
These oxidation results may also imply that the oxidation conditions are critical in 
antioxidant activity studies. If the oxidation is not strong or long enough, the differences in cell 
viability between the treated and control may be too subtle to be detected. Also, if the oxidation 
is too strong or too long, the excess tBHP may damage all cells. In either situation small but real 
differences between each antioxidant activity could not be determined.  
3.3.5 Antioxidant Activity and Possible Synergism of γ-Oryzanol, Ferulic Acid and α-
Tocopherol 
3.3.5.1 Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol at Different 
tBHP Oxidation Time 
Antioxidant activity of γ-oryzanol, ferulic acid and α-tocopherol was determined relative 
to the effectiveness in preventing tBHP oxidative damage for 0, 15, 30, 45 or 60 minutes on 
mitochondria in SVEC4-10 cells. When γ-oryzanol, ferulic acid or α-tocopherol was 
simultaneously present with tBHP for 1 hour, the results (Figure 3.9(a) and Appendix II(a)) 
showed that the overall effect of γ-oryzanol, ferulic acid or α-tocopherol on reducing tBHP 
damage in cells, regardless of the oxidation time, was not significantly different from the control 
(2% ethanol HBSS-emulsion). There was a significant oxidation time main effect (p<0.05), 
which means that the cell viability at each tBHP incubation time was different from each other 
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Figure 3.9. Antioxidant activity of γ-oryzanol, ferulic acid and α-tocopherol 
(a) with cells for 1 hour, (b) preincubated with cells for 
22 hours then removed, (c) preincubated with cells for 22 hours 
then added tBHP for 1 hour, and (d) preincubated with tBHP for
22 hours then added to cells for 1 hour
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the test solution and the oxidation time. All the test solutions were not significantly different 
from the control at oxidation time of 15, 30 or 45 minutes. Hence, it may imply that if present 
with tBHP simultaneously for 1 hour, γ-oryzanol, ferulic acid or α-tocopherol had no significant 
effect on preventing tBHP oxidative damage in cells. 
When the cells were preincubated with γ-oryzanol, ferulic acid or α-tocopherol for 22 
hours, washed and then oxidized by tBHP, the results showed that the type of test solution main 
effect was not significant, but the oxidation time main effect and the interaction of 
type×oxidation time were significant (p<0.05) (Figure 3.9(b) and Appendix II(b)). When the 
oxidation time effect was averaged out, the cellular mitochondrial activity of any test solution 
was significantly greater than that of the control (p<0.05). When the test solution effect was 
averaged out, the effect of tBHP oxidation time at 60 minutes was significantly the greatest 
(p<0.05) but at 15 or 30 minutes was not significant. Statistically, if there is no interaction, the 
differences of antioxidant activity between any two test solutions should remain the same at any 
oxidation time. In this case, there was an interaction between the type of test solution and the 
oxidation time indicating that the test solution that had higher antioxidant activity at shorter time 
of oxidation was not always higher at longer time of oxidation and vice versa. At 15 and 30 
minutes of oxidation, 0.50mM ferulic acid had the greatest antioxidant activity but had the 
lowest at 60 minutes. On the other hand, γ-oryzanol and α-tocopherol had an antioxidant activity 
not greater than ferulic acid at the early stage of incubation time but greater at the later stage. 
Therefore, it might imply that γ-oryzanol, ferulic acid and α-tocopherol all were associated with 
cells in some way and further protected cells from tBHP oxidative damage.  
When γ-oryzanol, ferulic acid or α-tocopherol were preincubated with cells for 22 hours 
without washing, the results (Figure 3.9(c) and Appendix II(c)) showed that the type of test 
  
solution main effect was not significant, but the oxidation time main effect and interaction of test 
type×oxidation time on cell viability were significant (p<0.05). Oxidation time longer than 30 
minutes was significantly different from 0 time (p<0.05), regardless of the type of the test 
solution. Similarly, the antioxidant activity of the control (2% ethanol HBSS-emulsion) was the 
lowest at any oxidation time. Ferulic acid had the greatest antioxidant activity, but was not 
significantly different from γ-oryzanol and α-tocopherol, at the oxidation time of 15 and 30 
minutes while α-tocopherol and γ-oryzanol had a greater antioxidant activity at oxidation times 
of 45 and 60 minutes, respectively. It may be suggested that the antioxidant activity of γ-
oryzanol, ferulic acid and α-tocopherol can extend to a greater degree if associated with the cells 
for 22 hours and continue to protect cells from tBHP oxidation. Also, ferulic acid may play a 
more important role in preventing tBHP damage at the early stage, then α-tocopherol and then γ-
oryzanol later. 
Finally, when test compounds were reacted with tBHP for 22 hours before being 
introduced to cells, the results (Figure 3.9(d) and Appendix II(d)) showed that there was a 
significant oxidation time main effect (p<0.05) and an interaction effect (p<0.05) but no test 
solution main effect. Regardless of the type of test solution, oxidation at any time was 
significantly higher than 0 time. Also, regardless of the oxidation time effect, γ-oryzanol, α-
tocopherol and ferulic acid did not have an antioxidant activity significantly different from the 
control. These relationships held true at most oxidation times.  
Thus, it may be suggested that the antioxidant activity mechanisms of γ-oryzanol, ferulic 
acid and α-tocopherol are different. When exposed to tBHP before cells, γ-oryzanol or ferulic 
acid had lower antioxidant activity than α-tocopherol. But when associated with cells, γ-oryzanol 
and ferulic acid can be more effective than α-tocopherol in preventing cell death. Thus, it may be 
  
speculated that association with cells, probably on the cell membrane, is necessary for γ-oryzanol 
and ferulic acid to protect cells from tBHP oxidation. Comparing the chemical structure of γ-
oryzanol with ferulic acid, the presence of the sterol or triterpene alcohol part in γ-oryzanol 
seems to alter the antioxidant activity of ferulic acid because γ-oryzanol did not always show 
higher antioxidant activity than ferulic acid. 
3.3.5.2 Antioxidant Activity of The Three Major Components of γ-Oryzanol 
As for the three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene 
cycloartanyl ferulate and campesteryl ferulate, their antioxidant activity was also compared to α-
tocopherol at different concentrations (0.05 to 0.5mM) by preincubation with the cells for 22 
hours, followed by cell washing and 12mM tBHP oxidation for 1 hour. The results (Figure 3.10 
and Appendix II(e)) showed that, neither the type of test solution main effect nor the 
concentration main effect was significant, but there was a significant interaction between the 
type of the test solution and the concentration level (p<0.05). At each of concentration levels 
from 0.05 to 0.25mM, α-tocopherol tended to have an antioxidant activity higher than the control 
but not significantly (p=0.2786, 0.1901 and 0.0784, respectively), except at 0.5mM where 24-
methylene cycloartanyl ferulate was the greatest and significantly greater than the control 
(p<0.05). It may be suggested that α-tocopherol is an effective antioxidant even at concentrations 
as low as 0.05mM. On the other hand, γ-oryzanol did not have significant antioxidant activity at 
each concentration level tested but there was a trend towards increased activity in a 
concentration-dependent manner. Although not significant, cycloartenyl ferulate and campesteryl 
ferulate at a concentration higher than 0.1mM tended to have a higher antioxidant activity than 
the control. At the lower concentration, the antioxidant activity of 24-methylene cycloartanyl 
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Figure 3.10. Antioxidant activity of the three major components of 
γ-oryzanol preincubated with cells for 22 hours and then 
tBHP oxidation for 1 hour
  
ferulate was not higher than cycloartenyl ferulate but was significantly higher at a concentration 
of 0.5mM (p<0.05). 
The three major components all prevented tBHP oxidative damage in SVEC4-10 cells to 
a degree greater than γ-oryzanol. In another study, the three major components of γ-oryzanol 
were found to be more effective than γ-oryzanol in their inhibitory effect on 12-o-
tetradecanoylphorbol-13-acetate-induced inflammation in mouse skin (Yasukawa et al., 1998). 
More research on whether or not the anti-inflammatory effect is related to their antioxidant 
activity is needed. Since the three components constitute about 70-80% of total γ-oryzanol, it 
may be suggested that these three components may be more responsible for the antioxidant 
activity of γ-oryzanol than other minor components.  
The antioxidant mechanism of ferulic acid has been evidenced from its potential of 
radical scavenging ability (Graf, 1992). Ferulic acid can form a phenoxy radical by donating a 
hydrogen atom to any reactive radical. The unpaired electron of ferulic acid radical can be 
delocalized across the entire molecule and thus becomes resonance stabilized. By comparing 
antioxidant activity and chemical structures, all of the γ-oryzanol components have the phenolic 
hydroxyl group in the ferulate portion, which can be a peroxyl-radical scavenger. In addition, 24-
methylene cycloartanyl ferulate has a methylene group at C-24 position attached to two alkyl 
groups while cycloartenyl ferulate has an alkene on C-24. The presence and the position of the 
double bond in the side chain of the terpene alcohol may also be related to its antioxidant 
activity.  
24-Methylene cycloartanyl ferulate exhibiting a higher antioxidant activity than the other 
two components of γ-oryzanol and α-tocopherol was also observed in preventing cholesterol 
oxidation induced by 2,2-azobis(2-methylpropionamidine) dihydrochloride (Xu et al., 2001). 
  
This may suggest that among the components of γ-oryzanol, 24-methylene cycloartanyl ferulate 
had a higher antioxidant activity than the other components and, given a high enough 
concentration, it can even be more effective than α-tocopherol in preventing SVEC4-10 cell 
damage. 
3.3.5.3 Synergistic Antioxidant Activity of γ-Oryzanol, Ferulic Acid and α-Tocopherol  
When simultaneously present with tBHP and cells for 1 hour, the combination of γ-
oryzanol+α-tocopherol+ferulic acid (at concentration of 0.33mM, 0.33mM and 0.2mM, 
respectively) decreased the tBHP damage to cells, compared to the control, or 1.0mM γ-oryzanol 
or 0.6mM ferulic acid alone (p<0.05) or 1.0mM α-tocopherol (p=0.1158) (Figure 3.11(a) and 
Appendix II(a)). When preincubated with cells for 22 hours, even though not significant, the 
combination of 0.25mM γ-oryzanol+0.25mM α-tocopherol tended to have higher antioxidant 
activity than the control (p=0.1747), 0.50mM γ-oryzanol alone (p=0.3463) or 0.50mM α-
tocopherol alone (p=0.7170) (Figure 3.11(b) and Appendix II(b)).  
Based on these results, it may be suggested that a synergistic antioxidant activity of γ-
oryzanol or ferulic acid with α-tocopherol possibly exists. α-Tocopherol has been studied 
extensively and is known for its function to inhibit lipid peroxidation by scavenging lipid peroxyl 
radicals to yield lipid hydroperoxides and a tocopheroxyl radical (Diplock et al., 1998). The 
tocopheroxyl radical is less reactive and acts as a chain-breaking antioxidant. Tocopherol can be 
regenerated from the tocopheroxyl radical by ascorbic acid and glutathione. The synergistic 
effect of ascorbic acid on antioxidant activity of α-tocopherol was found to regenerate α-
tocopherol because the ascorbyl radical not the tocopheroxyl radical was detected (Scarpa et al., 
1984). Therefore, it can be postulated that the synergistic antioxidant activity among γ-oryzanol, 
ferulic acid and α-tocopherol may be due to 1) the regeneration of α-tocopherol by γ-oryzanol 
Figure 3.11(a). Synergistic antioxidant activity of γ-oryzanol, ferulic 
acid and α-tocopherol simultaneously incubated with 
cells and tBHP for 1 hour. Significant differences (p<0.05) 
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Figure 3.11(b). Synergistic antioxidant activity of γ-oryzanol, ferulic 
acid and α-tocopherol preincubated with cells for 22 hours 
then added tBHP oxidation for 1 hour. Significant differences 
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and/or ferulic acid, 2) γ-oryzanol and/or ferulic acid spares α-tocopherol from radicals by 
quenching them, or 3) vice versa. Further investigation is required to understand the synergistic 
antioxidant mechanisms of γ-oryzanol, to identify the oxidized γ-oryzanol products and to 
develop the analytical method to detect them. 
In a cell model using cells with fast metabolism such as SVEC4-10 cells, the cell viability 
is dynamic even in the control situation for a relatively short period of time, not to mention when 
incubated with any test substance and HBSS for a longer time, thus the cell viability can vary 
widely. These studies also support the approach to interpret cellular mitochondrial activity as a 
percentage of treated (tBHP) over control (HBSS) and compares it to that of 2% ethanol HBSS-
emulsion at 0 treatment time. This mathematical adjustment may not be ideal but is fairly 
reasonable. 
3.3.6 Lipid Peroxidation Assays 
For the TBA-RS results, measuring the absorbances of the color products in standards 
and samples is recommended to scan absorbance spectrums for both standards and samples in 
every assay because the wavelengths for maximum absorbances can vary. Figure 3.12 showed 
that the maximum absorbance for TMP as standard was at 520nm but it was at 440-450nm for 
samples. The wavelength at 600nm was used to assess background interference in both standards 
and samples. The aim in this method would be to detect all substances reactive with TBA, which 
include not only malonaldehyde that produces a red pigment (at 520nm) but also alkanals, 
alkenals and 2,4-dienals that produce a yellow pigment (at 450nm). It has been suggested that it 
may be appropriate to measure both absorbances (Nawar, 1996). Thus, it may imply low 








Figure 3.12. Spectrum scan from 350 to 610nm for (a) standard TMP
(0.1µg/mL) and (b) TBA-reactive substances in cell 









The Bradford protein assay using Coomassie blue is the most widely used method and is 
commercially available as a kit. It measures protein content of cells to estimate total cellular 
material, which is often used as a denominator in expressions of, in this case, TBS-RS 
concentrations. It does not measure specific amino acids but is quite convenient. The maximum 
absorbances for BSA standards and samples were in a range from 595 to 640nm and absorbance 
at 790nm was used to assess background interference. Using SDS to solubilize protein or cells 
was not recommended because it could react with Bradford reagent. 
When the SVEC4-10 cells were preincubated with γ-oryzanol, ferulic acid, α-tocopherol, 
their combinations or the three major components of γ-oryzanol for 22 hours and then washed 
and treated with HBSS or tBHP for 1 hour, the results in terms of excess TBA-RS produced 
during oxidation per unit protein showed that there was no significant difference among these 
test compounds and the control (2% ethanol in HBSS-emulsion) (Figure 3.13). Even though the 
same test solutions in the same conditions were studied for their effect on preventing cellular 
mitochondrial damage from tBHP oxidation, the results were found to lack agreement between 
them. Similar to this case, it also has been reported that some antioxidants can reduce TBA-RS 
formation but did not preserve cell viability (Rush et al., 1985). The cytotoxicity of tBHP has 
been studied and postulated that lipid peroxidation may not be the main mechanism of tBHP 
cytotoxicity (Buc-Calderon et al., 1991).  
However, in this study the standard error for each test compound was relatively large, 
which implied poor reproductivity of this method. Furthermore, this method could not measure 
the TBA-RS released to solution during tBHP oxidation. Test solutions were always removed 
and cells were washed before testing because tBHP could react with TBA-RS reagent and give 
false positives. 
Figure 3.13. TBA-RS assay for antioxidant activity of γ-oryzanol, 
ferulic acid, α-tocopherol, their combinations and 
three γ-oryzanol major components preincubated with 
SVEC4-10 cells for 22 hours which were later treated 
with HBSS or 12mM tBHP for 1 hour. Significant 
differences (p<0.05) are expressed by different letters. 



































There were many disadvantages to the use of this TBA-RS method to study antioxidant 
activity of the compounds of interest, including poor reproductivity, low specificity and they are 
time and labor consuming. In addition, these TBA-RS experiments were scaled up using 8mL of 
each test solution and cells grown on 25cm2 surface area flasks (equivalent to 100µL to surface 
area of a well in a 96-well plate), in order to amplify the response signals. Nevertheless, the 
results did not show any significance. Therefore, it is very difficult to draw conclusions without 
further investigation. 
Another index of lipid peroxidation, conjugated diene formation, was also studied. 
However, the results showed that there was no peak detected at 234nm even in cells incubated 
with tBHP under conditions that would cause a marked decrease in cellular mitochondrial 
activity (Figure 3.14). Detecting lipid peroxidation has been known to be difficult due to the 
transient nature of lipid hydroperoxides and their decomposition (Aust, 1985). Therefore, it was 
not possible to distinguish the antioxidant activity of γ-oryzanol on lipid oxidation by introducing 
this method to the cell model developed for this study and whether or not the antioxidant activity 
of γ-oryzanol was responsible for preventing lipid peroxidation in cells was not delineated. A 
search in the future for other methods to approach this issue is necessary. 
3.4 Conclusion 
In this study, a cell model using SVEC4-10 mouse lymph endothelial cells, tBHP as 
oxidant agent and MTT for cell viability measurement was established and proven to be capable 
of distinguishing antioxidant activity of γ-oryzanol, ferulic acid, the three major components of 
γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate and campesteryl ferulate, 
from α-tocopherol. It was found that the SVEC4-10 cell line had a fast metabolism and 
consequently could be used to determine antioxidant activity of a test substance in a relatively 
Figure 3.14. Spectrum scan from 190 to 250nm for conjugated diene 
formation from chloroform/methanol/H2O extraction of 
SVEC4-10 cells treated with (a) HBSS or (b) tBHP 
















rapid manner. The critical and vital parameters relied on were 1) the emulsion preparation of 
hydrophobic compounds for cell model, 2) the consistent management of cell culture ready for 
antioxidant activity experiments, 3) the control of tBHP oxidation conditions such as 
concentration and time combinations and 4) the selection of cell viability detection methods 
compatible with the cell line and the test substances. 
In summary, γ-oryzanol and ferulic acid did possess antioxidant activity, in terms of 
preventing cellular mitochondrial damage due to tBHP oxidation. When preincubated with the 
SVEC4-10 cells, ferulic acid had higher antioxidant activity than γ-oryzanol and α-tocopherol at 
the early stage of oxidation (0 to 30 minutes) while γ-oryzanol and α-tocopherol tended to have 
higher antioxidant activity than ferulic acid at the late stage of oxidation (30 to 60 minutes). The 
three major components of γ-oryzanol generally had higher antioxidant activity than γ-oryzanol 
and in some situations presented more effective antioxidant activity than α-tocopherol. Among 
these three major components of γ-oryzanol, 24-methylene cycloartanyl ferulate was found to be 
relatively more effective. A synergistic antioxidant activity among γ-oryzanol, ferulic acid and 
α-tocopherol was also found when simultaneously present with tBHP for one hour. 
  
CHAPTER 4. HYPOCHOLESTEROLEMIC CAPACITY EXPERIMENTS USING AN IN 
VITRO HUMAN INTESTINAL CELL MODEL 
 
4.1 Introduction 
Another potential functionality of γ-oryzanol, hypocholesterolemic capacity, has been 
reported in a range of human and animal studies including rats and monkeys, which showed 
promising results for γ-oryzanol in reducing serum total, free, esterified and liver cholesterol 
levels. This research is the first attempt to develop an in vitro cell model using human intestinal 
cells and use it to demonstrate the possible mechanisms of hypocholesterolemic capacity of γ-
oryzanol. 
Since the digestive, absorptive and metabolic fate of γ-oryzanol is not clearly delineated 
and in view of the γ-oryzanol effect on enhancing cholesterol excretion, the potential mechanism 
by which γ-oryzanol decreases cholesterol uptake may be related to its action in the lumen of the 
gastrointestinal tract. In the human intestines, there are two sources of cholesterol. Typically one-
third comes from diet (exogenous source) and the remaining two-thirds from bile (endogenous 
source). It has been demonstrated that decreasing cholesterol uptake can lead to decreasing 
serum cholesterol. Therefore, this study focused on γ-oryzanol effects in the intestines to 
decrease cholesterol uptake.  
In order to approach this goal, one objective of this study was to develop an in vitro cell 
model using a human intestinal cell line to study cholesterol uptake and use a gas 
chromatography (GC) coupled with mass spectrometry (MS) to analyze cholesterol. In addition, 
since dietary cholesterol consists of two forms, free and esterified, the γ-oryzanol effect on the 
stability of micelles containing both forms of cholesterol or the availability of total cholesterol 
for uptake would be studied. Finally, the pancreatic enzymes, cholesterol esterase (CEase) and 
  
phospholipase A2, present in the intestines have been reported to promote cholesterol uptake 
(Mackay et al., 1997) and CEase is also responsible for hydrolyzing cholesteryl esters. 
Therefore, the possibility that γ-oryzanol inhibits or otherwise interferes with the activity of these 
enzymes would also be investigated. 
4.2 Materials and Methods 
4.2.1 Materials and Reagents 
γ-Oryzanol was obtained from crude rice bran oil using a preparative normal-phase high 
performance liquid chromatography (HPLC) and crude rice bran oil was extracted from milled 
rice bran according to the method developed by Xu and Godber (1999). The preparative HPLC 
system consisted of a Waters (Milford, MA) Prepak® RCM base connected with two cartridges 
(each 25mm×10cm Prep Nova-Pak HR silica with particle size 6µm) and a Guard-Pak insert, a 
U6K manual injector, a 510 pump and a Lambda-Max 481 LC Spectrophotometer (wavelength 
330 nm). Mobile phase was methanol with a constant flow rate at 15 mL/min and 2mL of the 
crude oil were injected each time. The eluate containing γ-oryzanol was collected (25-30min) 
and the solvent was evaporated. 
Cholesterol, cholesteryl oleate, oleic acid, 1-monoolein, lecithin, sodium taurocholate, 
MTT assay kit, Bradford reagent, Hanks balanced salts, porcine pancreatic cholesterol esterase, 
phospholipase A2 and trimethylsilylation reagents (N,O-bis(trimethylsilyl)trifluoroacetamide and 
trimethylchlorosilane (99:1)) were purchased from Sigma, St. Louis, MO. 
Tris(hydroxymethyl)aminomethane was purchased from Amresco, Solon, OH. HCl was 
purchased from Mallinckrodt, Inc., Paris, KY. NaOH, hexane and isopropanol were purchased 
from Fisher Scientific, Fair Lawn, NJ. Ethanol was USP absolute 200 proof purchased from 
AAPER Alcohol and Chemical Co., Shelbyville, KY. Culture plates were purchased from 
  
Corning Inc., Corning, NY, and the sterile disposable syringe filter was 0.2µm PES purchased 
from Whatman, Clifton, NJ. 
Tris-HCl buffer (0.1M) was prepared by dissolving 1.2114g of 
Tris(hydroxymethyl)aminomethane in about 90mL of distilled deionized water, adjusting pH to 
7.5 with 10N of HCl and diluting to 100mL volume with water. 
4.2.2 Micelle Preparation 
A modified method from Nagaoka et al., (1999), was used to prepare micelles containing 
cholesterol, cholesteryl oleate and/or γ-oryzanol in aqueous solutions. Cholesterol or cholesteryl 
oleate at a concentration of 0.2mM with or without 0.2mM γ-oryzanol was dissolved in 
hexane:isopropanol (3:1) with 1mM oleic acid, 0.5mM 1-monoolein and 0.6mM lecithin (final 
concentration). The solvent was evaporated using a vacuum evaporator (45oC, CentriVap 
Console, Labconco Inc., Kansas City, MO) and then 6.6mM sodium taurocholate in buffer or 
culture medium was added. Each solution was ultrasonicated (Sonic Dismembrator, Fisher 
Scientific, Fair Lawn, NJ) at output power of 10 watts for 45 minutes in an ice bath in order to 
ensure a clear solution free of precipitation. For cell culture experiments, micellar solutions were 
filtered through a 0.2µm filter for sterilization before being applied to cells. The cholesterol and 
cholesteryl oleate concentrations in the filtrate were later extracted and determined by GC/MS to 
ensure that cholesterol or cholesteryl oleate did not precipitate and that the micelle formation was 
successful.  
4.2.3 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol and Cholesteryl Oleate 
Cholesterol and cholesteryl oleate solubility in micelles with γ-oryzanol was measured by 
adding 10µL of ethanol or 10mM γ-oryzanol in ethanol to 990µL of 0.1mM of cholesterol or 
cholesteryl oleate micellar solution (final γ-oryzanol concentration was 0.1mM and ethanol was 
  
1%). The mixture was vortexed, incubated in a shaking water bath at 37oC for 24 hours and then 
ultracentrifuged (Beckman TL100 Ultracentrifuge, Beckman Instruments, Inc., Palo Alto, CA) at 
100,000×g at 37oC for 1 hour. The supernatant (500µL) was extracted to determine the γ-
oryzanol concentration by HPLC. The remaining samples were dried under vacuum for 
cholesterol or cholesteryl oleate analysis by GC/MS.  
4.2.4 Study of γ-Oryzanol Inhibition on CEase-Facilitated Cholesteryl Oleate Hydrolysis  
To study γ-oryzanol effect on CEase-facilitated cholesteryl oleate hydrolysis, first of all, 
the relationship between the substrate (cholesteryl oleate) concentration and the hydrolytic 
enzyme (CEase) concentration had to be determined since it could affect the reaction rate, by 
which an understanding of the enzyme kinetics and the possible inhibition mechanism by γ-
oryzanol could be obtained. Cholesteryl oleate micellar solution (1mL of 0.2mM in 0.1M Tris-
HCl buffer, pH 7.5) was incubated with a serial of concentrations of CEase from 0, 0.003, 0.03 
to 30µg protein/mL in a shaking water bath at 37oC for 5 minutes. After incubation, solvent 
extraction was immediately performed, followed by GC/MS to determine the concentration of 
cholesterol released from hydrolysis. The lowest CEase concentration that could result in a 
detectable amount of cholesterol significantly different from the control emulsion without CEase 
would be used to study the γ-oryzanol effect on CEase activity. 
To study γ-oryzanol effect on CEase inhibition, 1mL micellar solution containing 
cholesteryl oleate at concentrations of 0.05, 0.2 or 2mM with or without 0.1mM γ-oryzanol was 
incubated with CEase at 37oC for 5 minutes, immediately followed by solvent extraction and 
GC/MS determination of the amount of cholesterol released. The results would be expressed in a 
Michaelis-Menten plot (initial reaction rate versus substrate concentration) and a double-
reciprocal, or Lineweaver-Burk, plot (reciprocal of initial reaction rate versus reciprocal of 
  
substrate concentration). To determine the type of inhibition, if present, and the SAS system 
(version 8.2, SAS institute, Cary, NC) was used to compare the regression curve of the with γ-
oryzanol effect to the without γ-oryzanol curve. 
4.2.5 Cholesterol Uptake by Human Intestinal Cells In Vitro 
4.2.5.1 Cell Culture 
Human large intestinal cell line C2BBe1 (ATCC CRL-2102) was used to study 
cholesterol uptake. The cell line was maintained in 25-cm2 flasks with vent caps. To subculture, 
cells were washed three times using 0.25% trypsin (1mL each time). On the third time cells were 
kept in the trypsin solution for 10 minutes at 37oC. After cells detached, new medium (90% 
DMEM with 4mM L-glutamine, 1.5g/L sodium bicarbonate and 4.5g/L glucose and 
supplemented with 0.01mg/mL human transferrin; 10% fetal bovine serum) was added and the 
cell suspension was split into new 25-cm2 flasks (split ratio 1:3). For cholesterol uptake 
experiments, the cell suspension was diluted in new medium to 2x105 cells/mL and 1mL was 
transferred to each well (area=2cm2) of the 24-well culture plates, which resulted in 105cells/cm2. 
For cytotoxicity studies, 96-well plates were used and 100µL of the cell suspension was cultured 
in each well. Cell count was performed at each subculture to ensure consistency for each 
experiment. Cells were used for experiments when they reached confluency (about the 4th day 
after subculture). 
4.2.5.2 Cytotoxicity Studies of Micellar Solutions Using an MTT Assay 
Before being applied to the cells for the study of cholesterol uptake, all micellar solutions 
were investigated for their cytotoxicity. After reaching confluency in 96-well culture plates, the 
cells were gently washed using Hanks balanced salt solution (HBSS) twice and 100µL/well of 
each test solution was applied for 2 hours at 37oC. After incubation, the test solutions were 
  
discarded and the cells were gently washed again using HBSS, followed by a 3-(4,5-
dimethylthiazol-yl)-2-5-diphenyltetrazolium bromide (MTT) assay to measure cell viability in 
terms of the activity of mitochondrial dehydrogenases in living cells. The cells were incubated 
with 40µL/well of 1.25mg/mL MTT in HBSS, which is yellow in color, at 37oC in the dark for 2 
hours. The mitochondrial dehydrogenases of viable cells cleaved the tetrazolium ring and yielded 
purple formazan crystals, which are insoluble in aqueous solution. Then 100µL/well of MTT 
solubilization solution containing 10% Triton X-100 plus 0.1N HCl in anhydrous isopropanol 
was added to solubilize purple formazan crystals. Pipetting up and down at least 100 times 
helped solubilization in dense culture situation. Absorbances at 570nm for color development 
and at 690nm for background were read using a microplate spectrophotometer (SPECTRAmax® 
PLUS, Molecular Devices Co., Sunnyvale, CA). An increase or decrease of cell numbers after 
exposure to a test solution would correspond to a concomitant change in the amount of purple 
formazan formed or in the optical density at absorbance 570nm. The cell viability under 
exposure to a test compound was expressed in %cellular mitochondrial activity, which was the 
ratio of absorbance reading difference between 570nm and 690nm of test compound (A570 − 
A690) to that of the control (Ao570  Ao690): 
                         A570 − A690 
%Cellular mitochondrial activity  =    × 100% 
                             Ao570  Ao690   
4.2.5.3 Study of Cholesterol Esterase or Phospholipase A2-Promoted Cholesterol Uptake by 
Human Intestinal Cells In Vitro 
First of all, the cytotoxicity of 0.1mM cholesterol with or without CEase or 
phospholipase A2 up to 100µg protein/mL was studied. The concentrations of each enzyme that 
did not affect the cell viability significantly would be used to investigate whether or not these 
two enzymes could facilitate cholesterol uptake into cells as stated by Mackay et al., 1997, and if 
  
so, whether or not γ-oryzanol could affect the cholesterol uptake facilitated by these two 
enzymes. 
After reaching confluency, the cells were gently washed with HBSS twice and then 
incubated with 1mL of 0.1mM cholesterol micellar solution with or without each enzyme at 
various concentrations up to 100µg protein/mL for 2 hours at 37oC. After incubation, the test 
solutions were pipetted out and the cells were gently washed again with HBSS twice, followed 
by cell lysis for Bradford protein assay and cholesterol analysis as described in Section 4.2.7.2.  
4.2.6 Effect of γ-Oryzanol on Cholesterol Uptake by Human Intestinal Cells In Vitro 
4.2.6.1 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol  
Before the uptake experiments, cytotoxicity of cholesterol micellar solution with or 
without γ-oryzanol was studied. Cells were incubated with 100µL of 0.1mM cholesterol or a 
mixture containing 0.1mM cholesterol and 0.1mM γ-oryzanol for 2 hours at 37oC, followed by 
cell washing and MTT assay. For the study of γ-oryzanol effect on cholesterol uptake, the 
confluent cells were washed with HBSS twice and incubated with 1mL/well of micellar solutions 
containing 0.1mM cholesterol with or without 0.1mM γ-oryzanol for 2 hours at 37oC, followed 
by cell washing and cell lysis for Bradford protein assay and cholesterol analysis. Preincubation 
of cholesterol and γ-oryzanol in vials for 1, 2 or 6 hours at 37oC before being applied to cells for 
2 hours was also studied. 
4.2.6.2 Effect of γ-Oryzanol on Cholesteryl Oleate Hydrolysis 
First of all, cholesteryl oleate hydrolysis facilitated by various concentrations of CEase 
was studied in test tubes by incubating 1mL of 0.1mM cholesteryl oleate and CEase in a serial of 
concentrations from 0, 10-5 to 1µg protein/mL at 37oC for 2 hours, since the CEase concentration 
should be limited and 2 hours incubation time was required for cholesterol uptake into cells. The 
  
lowest concentration of CEase that resulted in significant cholesterol release from hydrolysis 
would be used to study the γ-oryzanol effect on CEase-facilitated cholesteryl oleate hydrolysis 
and consequently the availability of cholesterol in micelles, and the cholesterol uptake by human 
intestinal cells in vitro. 
Secondly, cytotoxicity of 0.1mM cholesteryl oleate with or without CEase up to 10µg 
protein/mL (37oC, 2 hours) was studied to determine if the micellar solutions and the enzyme 
mixture would decrease cell viability. The cholesterol uptake into the cells was then studied, 
where the only source of cholesterol for uptake resulted from 0.1mM cholesteryl oleate 
hydrolysis (37oC, 2 hours) facilitated by various concentrations (0.001 to 10µg protein/mL) of 
CEase. 
Thirdly, the γ-oryzanol effect on cholesteryl oleate hydrolysis and cholesterol, the 
product after hydrolysis, and uptake into cells was investigated by applying 0.1mM cholesteryl 
oleate with or without 0.1mM γ-oryzanol with 0.05µg protein/mL CEase to cells for 2 hours at 
37oC. The γ-oryzanol effect on micellar solubility of cholesteryl oleate and consequently its 
availability for hydrolysis catalyzed by CEase was also studied by preincubating 0.1mM 
cholesteryl oleate micellar solutions with or without 0.1mM γ-oryzanol in vials for 1 hour at 
37oC before being applied to cells for 2 hours at 37oC. After incubation, the cells were washed 
and lyzed for Bradford protein assay and cholesterol analysis.  
4.2.7 Solvent Extraction and Chemical Analysis 
4.2.7.1 Analysis of γ-Oryzanol Using HPLC 
To determine the γ-oryzanol concentration remaining in the micellar solutions, 
hexane/isopropanol (2:1:1) (×1) and hexane (×3) extraction was performed for each sample. The 
organic layers were collected, combined and evaporated under vacuum. The residue that 
  
remained was dissolved in mobile phase and ultrasonicated to help dissolve if necessary, 
followed by HPLC. 
A reverse-phase HPLC system developed by Xu and Godber (1999) was used to 
determine γ-oryzanol concentration. It consisted of a pump (Waters 510 HPLC Pump, Waters 
Co., Milford, MA), an autosampler (Waters 715 Sample Processor), a column (C18, 
25cm×4.6mm diameter, MICROSORB-MV 100 Å, Varian, Walnut Creek, CA) and a UV 
detector (wavelength 330 nm, Waters 486 Tunable Absorbance Detector). The mobile phase was 
methanol, acetonitrile, dichloromethane and acetic acid (50:44:3:3) with a flow rate maintained 
at 1.4 mL/min. One hundred µL of each sample was injected each time. Retention times for γ-
oryzanol was 5-9 minutes. Millenium32 software (Waters Co., Milford, MA) was used to record 
chromatograms and integrate peak areas. A standard curve of γ-oryzanol (concentration versus 
integrated area) was constructed to determine γ-oryzanol concentration in samples. 
4.2.7.2 Cholesterol Analysis by GC/MS and Bradford Protein Assay 
To determine cholesterol concentration in cell samples after treatment with test solutions, 
the cells were washed with HBSS twice and cell lysis was accomplished using 400µL/well of 1N 
NaOH at 37oC for 30 minutes, neutralized in 400µL/well of 1N HCl and pipetting up and down 
to break cell clumps to make a homogeneous cell suspension. Bradford protein assay was 
performed first to determine the amount of cell protein in the cell suspension. Two aliquots of 
20µL homogenized cell suspension were diluted to 1mL with distilled deionized water and then 
mixed with 1mL of Bradford protein reagent. After 5 minutes at room temperature in the dark, 
the spectrum from 350 to 800nm was scanned first using a spectrophotometer to choose 
wavelengths for the maximum absorbance and the background. A serial dilution of bovine serum 
albumin at 0, 2, 4, 6µg/mL was used to construct a standard curve (concentration versus 
  
absorbance (Amax−Abackground)). The crude protein concentration in each cell sample was 
calculated by converting the absorbance to concentration using the standard curve and 
multiplying the proper dilution factor. 
The remaining cell suspension was spiked with 25µL of 1mM β-sitosterol in isopropanol 
as an internal standard and then extracted using hexane:isopropanol (3:1) (×1) and hexane (×3). 
A sample of cell suspension without being spiked with β-sitosterol after cells were incubated 
with 0.1mM γ-oryzanol micellar solution for 2 hours at 37oC and washed with HBSS twice was 
also tested to determine whether or not β-sitosterol existed. The organic layers were collected, 
combined and mixed with sodium sulfate anhydrous to remove water. The solvent was 
evaporated under vacuum. To determine cholesterol concentration, each sample with dried 
residue from cell suspension or micellar solution after γ-oryzanol analysis by HPLC was 
derivatized first with 100µL of trimethylsilylation reagents, N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) and trimethylchlorosilane (TMCS) (99:1), and 
100µL pyridine to remove any possible water that could also react with the trimethylsilylation 
reagents. After incubation in a shaking water bath at 30oC for 2 hours, all samples were stored at 
4oC until GC analysis, which was usually done within 24 hours.  
The GC system (Varian CP-3800, Walnut Creek, CA) consisted of a glass injection port 
(splitless, 300oC) and a fused silica capillary column with low polarity (SPB-5, 30m x 0.25mm 
diameter and 0.1µm film thickness, Supelco Inc., Bellefonte, PA). The oven temperature was 
ramped from 100oC to 280oC with heating rate of 3oC/min and helium was the carrier gas 
maintained at a flow rate of 1.0mL/min. One µL of each sample was injected with split ratio 0 
from 0-0.2 minutes and 10000 from 0.2-60 minutes. The GC system was coupled with an MS 
detector (Varian Saturn 2200) with the following conditions: trap temperature 170oC, manifold 
  
temperature 65oC and transfer line temperature 170oC; axial modulation 3.9 volts; mass range, 
m/z 45-650; EI auto ionization mode: scan time 0.39 seconds/scan, emission current 10µamps, 
pre-scan ionization time 100 µsecond and maximum ionization time 25000 µsecond. 
The quantitation ions for area integration were 330+354+369+458 m/z for cholesterol and 
397+358+382+487 m/z for β-sitosterol. The standard curves of cholesterol and β-sitosterol were 
constructed (concentration versus peak area). Total cholesterol concentration in each cell sample 
was normalized with β-sitosterol and expressed in µmole cholesterol/mg cell protein.  
Statistical analysis used proc mix in SAS version 8.2 (SAS Institute Inc., Cary, NC) (see 
Appendix I for SAS codes). 
4.3 Results and Discussion 
4.3.1 Cholesterol Analysis by GC/MS and Internal Standard 
After treatment, cells were usually lyzed in 1N NaOH or 1% sodium dodecyl sulfate 
(SDS) in order to prepare them for GC/MS analysis. Since lipid extraction would be performed 
later, NaOH was used instead of SDS, which could also be extracted and complicate the analysis. 
In this case, cholesteryl esters if present would be hydrolyzed to the free form of cholesterol in 
1N of NaOH. Therefore, the cholesterol concentration measured was the total amount of 
cholesterol in cell suspension, including free and ester forms of cholesterol.  
To determine the amount of cholesterol uptake into cells in vitro, cholesterol labeled with 
radioisotopes such as 3H or 14C and scintillation counter to measure radioactivity have typically 
been used. However, in this study GC/MS was used instead. There are several disadvantages to 
using radioisotopes including the safety issue and inconvenience such as that involving lipid 
extraction and other methods (i.e. thin layer chromatography) to separate the labeled compounds 
in the mixture and cleaning up waste, tools and machinery after use. On the other hand, GC/MS 
  
provided a means to measure both free and ester forms of cholesterol or other substances 
simultaneously.  
α-Cholestane has usually been used as an internal standard in cholesterol analysis, but in 
this case, because it had the same retention time as cholesteryl oleate under GC/MS analysis, it 
could interfere with the determination of certain ions selected for area integration in the 
calculation of concentration. β-Sitosterol was then used as an internal standard in this study 
because its chemical structure is similar to cholesterol. Also, β-sitosterol resulting from γ-
oryzanol uptake into cells was not found in cell suspension determined by GC/MS and the CEase 
concentration used for cholesteryl ester hydrolysis was only 0.05µg protein/mL, which did not 
degrade γ-oryzanol and produce β-sitosterol (see the next chapter and Figure 5.7). Therefore, β-
sitosterol concentration was not overestimated and it could be used as an internal standard in cell 
samples. 
4.3.2 Effect of γ-Oryzanol on Micellar Solubility of Cholesterol and Cholesteryl Oleate 
After 24-hour incubation of 0.1mM cholesterol or cholesteryl oleate micellar solution 
spiked with 0.1mM γ-oryzanol, cholesterol, cholesteryl oleate and γ-oryzanol all lost some 
degree of micellar solubility in this in vitro model. However, there were no significant 
differences after incubation with or without γ-oryzanol in cholesterol (p=0.5622) or in 
cholesteryl oleate (p=0.3597) recovered in the supernatant of the micellar solution (Figure 4.1(a) 
and (b) and Appendix III(a)). There was a tendency towards lower %recovery of cholesteryl 
oleate in the supernatant micelles than that of cholesterol, which indicated that γ-oryzanol might 
be more likely to affect cholesteryl oleate than cholesterol. The reasons may be related to 
differences in polarity and molecular weight. The polarity of cholesterol is higher with the free 
hydroxyl group than when it is esterified with a fatty acid. When forming a micelle in the 
Figure 4.1. Effect of γ-oryzanol on micellar solubility of cholesterol and 
cholesteryl oleate. (n=2×2 replications. Significant differences 
(p<0.05) are expressed by different letters.)
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aqueous environment, the hydrophobic regions are in the interior while the hydrophilic regions 
are at the surface. As a larger molecule that is less polar, cholesteryl oleate would occupy more 
of the emulsifiers hydrophilic regions to remain stable in the micelle. With the fixed micellar 
composition, it is reasonable that the micellar solubility of cholesteryl oleate was affected more 
by γ-oryzanol, which is also a large molecule with low polarity. 
Similarly, from the aspect of γ-oryzanol competing with cholesterol and cholesteryl 
oleate for the limited micellar space, %recovery of γ-oryzanol in the supernatant of micellar 
solution was significantly lower with the presence of cholesteryl oleate than that with cholesterol 
(p<0.05) (Figure 4.1(c) and Appendix III(a)). This may also explain why micellar solubility of 
cholesteryl oleate was disturbed to a greater degree by γ-oryzanol.  
Therefore, since hydrophobic substances such as cholesterol and cholesteryl oleate must 
form micelles in order for digestion and absorption in the human intestines, γ-oryzanol may have 
an effect to exclude cholesterol and cholesteryl oleate from the micelles and consequently may 
decrease the availability of cholesteryl oleate for hydrolysis and cholesterol for uptake into cells. 
4.3.3 Effect of γ-Oryzanol on Cholesterol Esterase-Facilitated Cholesteryl Oleate Hydrolysis 
Before the study of the γ-oryzanol effect, cholesteryl oleate hydrolysis facilitated by a 
serial concentration of CEase was investigated. The results showed that CEase was responsible 
for the release of cholesterol from cholesteryl oleate and the degree of cholesteryl oleate 
hydrolysis depended on the concentration of CEase (Figure 4.2). The higher the CEase 
concentration, the more cholesterol was released from cholesteryl oleate hydrolysis. In order to 
study the inhibitory effect of γ-oryzanol, the CEase concentration should be limited and much 







0.0001 0.001 0.01 0.1 1 10 1000
~~













Figure 4.2. Cholesteryl oleate hydrolysis dependent on 
a serial concentration of cholesterol esterase,
37oC, 5 minutes
  
was the lowest concentration that showed significantly different activity from the control (no 
enzyme) (p<0.05) in the production of detectable cholesterol. 
A commonly used approach to studying enzyme mechanisms is through the use of the 
Michaelis-Menten equation, which was adapted in order to understand the inhibition effect of γ-
oryzanol on CEase. One of the fundamental concepts in this approach is that the substrate 
concentration affects the rate of a reaction catalyzed by an enzyme. However, it is complicated to 
study substrate concentration effect since it changes over the reaction period. To simplify, the 
very short time following the start of the reaction, when the substrate concentration is much 
greater than the enzyme concentration, is studied instead. At the beginning, enzyme is mixed 
with the excess amount of substrate and the enzyme-substrate complex (ES) builds up quickly, 
which is called the pre-steady state and is usually too short to measure. Then a steady-rate state is 
achieved, in which the ES reaches equilibrium where the rate of ES breakdown is equal to ES 
formation. This kind of analysis is referred to as steady-state kinetics with the basic hypothesis 
by Michaelis and Menten that ES breakdown to free enzyme and product is the rate-limiting step 
in the reaction.  
The initial reaction rate (or initial velocity), designated Vo, reflects the steady state and is 
determined by the ES breakdown to give product. In this case, Vo was measured as the rate of the 
product (cholesterol) concentration over the time of the early (first 5 minutes) reaction. The 
relationship between Vo and the substrate (cholesteryl oleate) concentration with a constant 
enzyme (CEase) concentration was constructed (Figure 4.3). It showed that if the cholesteryl 
oleate concentration reach infinity, Vo reaches constant at its maximum, designated Vmax, and 
when Vo equals to a half of the Vmax, the cholesteryl oleate concentration equals to Michaelis-
Menten constant, designated Km. The type of inhibition mechanism of γ-oryzanol could then be 
  
determined by comparing Km1 and Vmax1 values without γ-oryzanol to Km2 and Vmax2 values with 
γ-oryzanol. 
With these concepts, the study of the γ-oryzanol effect was done by incubating 0.2mM 
cholesteryl oleate with 0.1µg protein/mL CEase with or without 0.2mM γ-oryzanol at 37oC for 5 
minutes. Even though Vo means initial rate in a sufficiently short time at the beginning of the 
reaction, incubation time less than 5 minutes was difficult to access and this approach was also 
used in the study of CEase activity by Mackay et al., 1997. No internal standard was used in this 
case because β-sitosterol may be produced from γ-oryzanol degradation catalyzed by CEase and 
there was no proper internal standard in this case. The results expressed in Michaelis-Menten 
plot (Figure 4.3) showed that the effect of cholesteryl oleate concentration on cholesterol release 
was significant, which demonstrated the fundamental concept of this approach that the substrate 
concentration affects the rate of the reaction catalyzed by an enzyme.  
By transforming a Michaelis-Menten plot to a double-reciprocal, or Lineweaver-Burk 
plot, 1/Vo (Y) versus 1/[cholesteryl oleate] (X) becomes a simple linear relationship 
(Y=βo+β1X), where the intercept (βo) equals to 1/Vmax and the slope (β1) equals to Km/Vmax. The 
type of inhibition mechanism of γ-oryzanol could then be more easily observed (Figure 4.4) and 
compared by the changes of Km1 and Vmax1 of the straight line without γ-oryzanol to that, Km2 
and Vmax2, with γ-oryzanol. 
Relative to γ-oryzanol inhibition, Km1 was not significantly different from Km2 and Vmax1 
was also not significantly different from Vmax2. Although not significant, the divergence in the 
plots might still suggest that γ-oryzanol tended to decrease Vmax. This means that, with the 
presence of γ-oryzanol, reaction rate inclined to be lower possibly because γ-oryzanol may bind 


































Figure 4.3. Michaelis-Menten plot of 0.2mM γ-oryzanol inhibition on 
0.1µg protein/mL cholesterol esterase-facilitated cholesteryl 
oleate hydrolysis, 37oC, 5 minutes. (n=2×2 replications)
Figure 4.4. Lineweaver-Burk plot of 0.2mM γ-oryzanol inhibition on 
0.1µg protein/mL cholesterol esterase-facilitated cholesteryl 
oleate hydrolysis, 37oC, 5 minutes. (n=2×2 replications)
y = 3.475x + 25.045
R2 = 0.958





































= Km / Vmax
  
would decrease. However, the substrate concentration required (Km2) to reach 1/2Vmax2 remained 
the same as that (Km1) needed to reach 1/2Vmax1 without γ-oryzanol, which means that γ-oryzanol 
may bind to CEase at a site distinct from that which binds cholesteryl oleate. Thus, the 
inactivation occurred with or without the presence of cholesteryl oleate. This type of inhibition is 
referred to as noncompetitive inhibition. Therefore, it may be suggested that γ-oryzanol might 
have a tendency towards the inhibition of CEase and consequently the release of cholesterol from 
the hydrolysis was lowered. The reason may be the combined effects of γ-oryzanol on CEase 
inhibition and micellar solubility of cholesteryl oleate (less available for hydrolysis).  
The mechanism of enzyme inhibition can be complicated, especially with measuring the 
initial velocity at the very beginning of the reaction. Also, it requires that the substrate 
concentration should be much higher than the enzyme concentration but it is unclear how high is 
acceptable. In addition, determination of the product concentration depends on the detection limit 
of the analytical method employed, which means the concentration of the product may be too 
low to be detected at the initial stage of the reaction. The greatest degree of CEase inhibition by 
γ-oryzanol may simply not be measured at the most appropriate moment. The use of an 
appropriate internal standard is also important if GC/MS is employed. More research is needed 
to further understand the characteristics of CEase, such as the hydrolytic steps from binding 
cholesteryl oleate to releasing cholesterol and the reaction rates, the active site of CEase 
responsible for cholesteryl ester hydrolysis and the γ-oryzanol binding site. Also, it must be 
determined if regulation of CEase by other substances is present and if the CEase inactivation 
will affect the digestion and metabolism of other compounds.  
  
4.3.4 Cholesterol Uptake by Human Intestinal Cells In Vitro 
In this study, the cell line used was C2BBe1, a brush border expressing human colon cell 
line cloned from the Caco-2 cell line (ATCC HTB-37), which is derived from a human colon 
adenocarcinoma which has been used as a model in many studies of cholesterol uptake into the 
intestinal mucosa. Besides C2BBe1, another cell line Fhs74Int (ATCC CCL-241), a human 
normal small intestine cell line, was also cultured with the intention to study cholesterol uptake 
in vitro. However, the cells required a relatively long time (2 weeks) to reach confluency and had 
limited passages before the onset of senescence. Therefore, the C2BBe1 cell line was developed 
to be a model for in vitro cholesterol uptake studies.  
4.3.4.1 Effect of Cholesterol Esterase and Phospholipase A2 
The results of cytotoxicity studies (Figure 4.5) showed that 0.1mM cholesterol with or 
without CEase or phospholipase A2 up to 100µg protein/mL at 37oC for 2 hours did not decrease 
cell viability in terms of cellular mitochondrial activity, compared to the control, serum-free and 
transferrin-free culture medium. For the effect of CEase and phospholipase A2 on cholesterol 
uptake, the results (Figure 4.6) showed that neither enzyme up to 100µg protein/mL significantly 
increased cholesterol uptake into cells. Therefore, the study of the γ-oryzanol effect on 
cholesterol uptake could not address the possibility that γ-oryzanol could inhibit CEase and 
phospholipase A2 activity. Rather the focus of this experiment became the effect of γ-oryzanol on 
the micellar solubility of cholesterol. 
Initially, the study of the γ-oryzanol effect on CEase and phospholipase A2 was motivated 
by the results from Mackay et al., 1997, who suggested that CEase and phospholipase A2 could 
promote cholesterol uptake by hydrolyzing phosphatidylcholine, one of the components used to 
prepare cholesterol in micelles, and therefore altering the physicochemical state of cholesterol in 
Figure 4.5. Cytotoxicity study of cholesterol incubated with γ-oryzanol, 
cholesterol esterase or phospholipase A2 at 37oC for 2 hours
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Figure 4.6. Effect of cholesterol esterase or phospholipase A2 on
cholesterol uptake into human intestinal cells in vitro, 
37oC, 2hours. (n=2×3 replications)
phospholipase A2
  
the intestines. However, the same results were not observed in this compared with other studies 
(Shamir et al., 1995, and Huang and Hui, 1990). One of the possible reasons is that all studies 
used different micellar compositions. The micelles used in this study to prepare cholesterol, 
cholesteryl oleate and γ-oryzanol in aqueous solution consisted of relatively high concentrations 
of oleic acid (0.5mM), 1-monoolein (0.25mM) and phosphatidylcholine (0.3mM), since 
preparing γ-oryzanol micellar solution has been a challenge. Hence, micellar composition is 
critical in the investigation of micellar solubility of cholesterol or γ-oryzanol.  
Moreover, while the molecule weight was not provided by the manufacturer, the 
concentrations of CEase and phospholipase A2 could not be expressed in terms of molarity and 
be compared to the concentrations used in other studies. The concentrations of CEase and 
phospholipase A2 in this study may not be sufficiently high enough to promote cholesterol 
uptake. In summary, the lipid composition of micelles in human intestines is very complicated 
and therefore, more research is needed to further understand the roles of CEase and 
phospholipase A2 in promoting cholesterol uptake. 
4.3.4.2 Effect of γ-Oryzanol on Availability of Cholesterol for Uptake 
First of all, the results of cytotoxicity studies showed that 0.1mM cholesterol with or 
without 0.1mM γ-oryzanol did not decrease cellular mitochondrial activity compared to the 
control, serum-free and transferrin-free culture medium (Figure 4.5). As for the cholesterol 
uptake, the concentration of cholesterol recovered from the cell suspension was significantly 
higher in cells incubated with cholesterol than that in the control emulsion without cholesterol 
(p<0.05) (Figure 4.7 and Appendix III(b)). Since cholesterol is one of the natural constituents in 
the cell membrane of animal cells, even the control sample should test positive for cholesterol 
Figure 4.7. Effect of γ-oryzanol preincubated with cholesterol for 0, 1, 2 
or 6 hours on cholesterol uptake into human intestinal cells 
in vitro, 2 hour, 37oC. (n=2×3 replications. Significant 





































and the extra cholesterol must have resulted from the cholesterol uptake into cells or association 
with cells. 
The results also showed that, with or without the presence of γ-oryzanol, the cholesterol 
concentrations recovered were not significantly different (p=0.6808). When cholesterol and γ-
oryzanol were preincubated in vials for up to 6 hours before being applied to cells, the 
concentrations of cholesterol recovered from cell suspensions tended to decrease more obviously 
in a time-dependent manner. The longer the preincubation, the less cholesterol recovered. 
Preincubation time for two hours did not show a significant difference (p=0.2105) but it showed 
a significant decrease after six-hour preincubation (p<0.05) to a level equivalent to the control. 
The preincubation of cholesterol alone for 6 hours caused less cholesterol uptake than without 
preincubation but not significantly. Therefore, preincubation with γ-oryzanol for 6 hours had a 
significant effect on decreasing cholesterol uptake and it may be due to the decreased cholesterol 
micellar solubility in preincubation.  
4.3.4.3 Effect of γ-Oryzanol on Cholesteryl Oleate Hydrolysis 
The results of the relationship between various concentrations of CEase and the 
cholesterol released from hydrolysis is shown in Figure 4.8. The relationship was concentration-
dependent, which means that the more CEase catalyzed the hydrolysis, the more cholesterol was 
produced. The concentration range studied was only up to 1µg protein/mL, which resulted in 
only about 5% cholesterol production. It was postulated that, when applied to cells, the reaction 
direction would go in favor of releasing products, which would be taken up into cells, and the 
hydrolysis may not reach equilibrium. Therefore, CEase at concentration as low as 0.05µg 
protein/mL was significantly different from the control (no enzyme) (p<0.05) and was sufficient 























Figure 4.8. Cholesterol esterase concentration effect on 
cholesteryl oleate hydrolysis, 37oC, 2 hours
  
As for the cytotoxicity studies, the results showed that 0.1mM cholesteryl oleate with or 
without CEase up to 10µg protein/mL did not decrease cellular mitochondrial activity compared 
to the control, serum-free and transferrin-free culture medium (Figure 4.9). For the uptake 
studies, the results showed that, after cholesteryl oleate was incubated with cells, there was no 
significant cholesterol uptake compared to the control emulsion (Figure 4.10 and Appendix 
III(c)). The results also agreed with Mackay et al., 1997, that the ester form of cholesterol could 
not be absorbed without prior hydrolysis. The dietary cholesteryl esters are usually hydrolyzed 
by pancreatic CEase to free cholesterol in intestines before uptake. It also showed that when 
cholesteryl oleate was incubated with 0.05µg protein/mL CEase, there was significantly higher 
cholesterol concentration detected in the cell suspension (p<0.05). Thus, the results suggested 
that cholesteryl esters could not be absorbed by intestinal cells, and in order for uptake, 
hydrolysis catalyzed by CEase was necessary. The study of γ-oryzanol effect would then focus 
on inhibition on CEase hydrolytic activity and micellar solubility of cholesteryl oleate 
(availability for hydrolysis). 
First of all, the cytotoxicity results showed that γ-oryzanol incubated with cholesteryl 
oleate and CEase did not decrease the mitochondrial activity of cells (Figure 4.9). Secondly, with 
the presence of γ-oryzanol, the uptake of cholesterol resulted in a trend towards decreased 
cholesteryl oleate hydrolysis (p=0.1392) (Figure 4.10 and Appendix III(c)). The reason may be 
due to the combined effects of γ-oryzanol on micellar solubility of cholesteryl oleate and 
cholesterol, and on CEase inhibition. It may be suggested that when γ-oryzanol and cholesteryl 
oleate are simultaneously present in the intestines, γ-oryzanol can affect the cholesteryl oleate 
hydrolysis and then decrease the cholesterol uptake into cells.  
Figure 4.9. Cytotoxicity study of cholesteryl oleate incubated with
γ-oryzanol and cholesterol esterase at 37oC for 2 hours






















Figure 4.10. Effect of γ-oryzanol preincubated with cholesteryl oleate 
for 0 or 1hour before cholesterol esterase-facilitated hydrolysis 
on cholesterol uptake into human intestinal cells in vitro, 
2 hour, 37oC. (n=2×3 replications. Significant differences 
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Furthermore, after preincubation with γ-oryzanol in vials at 37oC for 1 hour, cholesteryl 
oleate hydrolysis by 0.05µg protein/mL CEase resulted in a trend towards lower cholesterol 
uptake (p=0.1546) (Figure 4.10 and Appendix III(c)). This may be because γ-oryzanol disturbed 
the micellar solubility of cholesteryl oleate or decreased the availability of cholesteryl oleate for 
hydrolysis and cholesterol production, and therefore decreased cholesterol uptake. Thus, it may 
be suggested that if γ-oryzanol is present with cholesteryl oleate for more than one hour before 
interacting with CEase in the intestines, the availability of cholesteryl esters may decrease further 
due to competition with γ-oryzanol and by being excluded from micelles. After interacting with 
CEase, hydrolysis of cholesteryl esters might be inhibited by γ-oryzanol resulting in less free 
form of cholesterol available for uptake and also the micellar solubility of the hydrolysis product, 
cholesterol, may decrease, thus the cholesterol uptake into cells may consequently decrease. 
Additionally, differences occurred in the preincubation times required for γ-oryzanol to 
reduce cholesterol uptake between free cholesterol and cholesteryl ester. Preincubation of γ-
oryzanol with cholesteryl oleate for 1 hour before being introduced to cells showed an effect on 
cholesterol uptake relatively greater than preincubation with free cholesterol. The reason may be 
due to their chemical structures and the stability of micelles as stated in Section 4.3.2. Free 
cholesterol is more hydrophilic than its ester form and, reasonably, to decrease its micellar 
solubility may take a longer time than with the esters. Therefore, it suggested that, in the 
gastrointestinal tract before uptake, γ-oryzanol might play a bigger role in affecting micellar 
solubility of cholesteryl esters than in affecting the free form of cholesterol. 
Finally, when enzymes are involved, the mechanism of inhibition can be complicated. 
For example, the hydrolysis and uptake of cholesterol, which was the product from the 
hydrolysis, most likely occur simultaneously. Consequently, the reaction would not reach 
  
equilibrium because the product concentration would not increase over time (due to uptake into 
cells) and the reaction direction would go toward the product. Even a small amount of CEase 
may be able to facilitate hydrolysis over time as was the case with the CEase at the higher 
concentration in this study. Hence, the γ-oryzanol effect on CEase inhibition might be difficult to 
detect. Thus, the focus of this study became the γ-oryzanol effect on micellar solubility of 
cholesteryl oleate, or availability of cholesteryl oleate for hydrolysis. 
4.4 Conclusion 
Many researchers have studied and found that γ-oryzanol possesses hypocholesterolemic 
capacity. However, this is the first time that the possible mechanism of this γ-oryzanol function 
has been approached. In addition, a cell model using human intestinal cells accompanied with 
GC/MS was developed and found capable of detecting cholesterol uptake into cells in vitro. 
The mechanism of the hypocholesterolemic capacity of γ-oryzanol is complicated. Since 
the results of digestibility and absorbability of γ-oryzanol suggested that γ-oryzanol is poorly 
absorbed by intestinal cells (see next chapter), therefore, γ-oryzanol may affect cholesterol 
uptake as it takes place in the lumen of the gastrointestinal tract. This study tried to distinguish 
the avenues that γ-oryzanol may influence and then develop a model to investigate the γ-oryzanol 
effect from each aspect. 
From the results, the hypocholesterolemic capacity of γ-oryzanol could be envisioned 
from three standpoints. 1) Because the uptake of cholesteryl oleate was not found but the 
hydrolysis catalyzed by CEase that generated free cholesterol was, γ-oryzanol may affect the 
availability of cholesteryl esters for CEase-facilitated hydrolysis by reducing the micellar 
solubility of cholesteryl esters. 2) Since dietary cholesteryl esters are usually hydrolyzed by 
pancreatic CEase in the small intestines, and CEase was not found to promote free cholesterol 
  
uptake, the effect of γ-oryzanol focused on the inhibition of hydrolytic function of CEase, which 
was to inhibit the hydrolysis of cholesteryl esters and reduce free cholesterol production. 3) 
Because it was not found that the uptake of free cholesterol was promoted by CEase and 
phospholipase A2, γ-oryzanol may affect the availability of free cholesterol for uptake by 
decreasing its micellar solubility. Therefore, consequently, the cholesterol uptake into cells 
decreased. 
Some researchers also studied the binding of bile salts (i.e. Nagaoka et al., 1999, and 
Ikeda et al., 1992) as a mechanism for serum cholesterol reduction. Bile salts are excreted by the 
liver and stored in and released from gallbladder to duodenum in response to digestion. They are 
amphipathic with both hydrophilic and hydrophobic regions and function as emulsifiers to 
prevent gallstone formation resulting from the precipitation of cholesterol in bile and to form 
micelles containing dietary lipids. Hence, it is reasonable that researchers should also consider 
the study of the effects of γ-oryzanol on binding bile salts since the reduction of bile salt 
availability for micelle formation in the small intestines would result in a decrease of micellar 
solubility of cholesterol along with other lipids.  
In order to do so, what must be kept in mind, however, is the analytical method to 
measure bile salts, i.e. enzymatic assay using hydroxysteroid dehydrogenase should have 
specificity to bile salts only and not react with γ-oryzanol to give false positives. This is because, 
unlike the soy protein peptic hydrolysate in the study by Nagaoka et al., 1999, and tea catechins 




CHAPTER 5. IN VITRO DIGESTIBILITY AND ABSORBABILITY OF γ-ORYZANOL 
 
5.1 Introduction 
The absorption and metabolism of γ-oryzanol in human or animal bodies has not been 
fully delineated. There are only a few of studies in English exploring this phenomenon. Many of 
the studies done in the area have used animal models such as rabbits and rats (Fujiwara et al., 
1983). Measurement of γ-oryzanol and its metabolites in those studies employed thin layer 
chromatography, which was the only method available prior to the development of modern 
chromatographic approaches to analysis. 
Therefore, with the assistance of liquid chromatography, gas chromatography coupled 
with mass spectrometry and cell culture techniques, the objective of this study was to investigate 
the metabolic fate of γ-oryzanol in the gastrointestinal tract by an in vitro model involving 
simulated peptic and pancreatic digestion and by cell culture using human intestinal cells. The 
effect of three specific pancreatic enzymes, cholesterol esterase (CEase), lipase and 
phospholipase A2, on γ-oryzanol degradation and the identification of the degradation products 
were studied. 
5.2 Materials and Methods 
5.2.1 Materials and Reagents 
γ-Oryzanol was obtained from crude rice bran oil using preparative normal-phase high 
performance liquid chromatography (HPLC) and crude rice bran oil was extracted from milled 
rice bran according to the method developed by Xu and Godber (1999). The preparative HPLC 
system consisted of a Waters (Milford, MA) Prepak® RCM base connected with two cartridges 
(each was a 25mm×10cm Prep Nova-Pak HR silica with particle size 6µm) and a Guard-Pak 
insert, a U6K manual injector, a 510 pump and a Lambda-Max 481 LC Spectrophotometer 
  
(wavelength 330 nm). Mobile phase was methanol with a constant flow rate at 15 mL/min and 
2mL of the crude oil were injected each time. The eluate containing γ-oryzanol was collected 
(25-30min) and the solvent was evaporated. 
Oleic acid, 1-monoolein, lecithin, sodium taurocholate, ferulic acid, stigmasterol, 
Na2HPO3, MTT assay kit, Bradford reagent, Hanks balanced salts, porcine bile extract, porcine 
pepsin, porcine pancreatin, containing many enzymes including amylase, trypsin, lipase, 
ribonuclease and protease, porcine pancreatic cholesterol esterase, lipase, phospholipase A2 and 
trimethylsilylation reagents (N,O-bis(trimethylsilyl)trifluoroacetamide and trimethylchlorosilane 
(99:1)) were purchased from Sigma, St. Louis, MO. HCl and NaHCO3 were purchased from 
Mallinckrodt, Inc., Paris, KY. NaOH, NaCl, KH2PO3, hexane and isopropanol were purchased 
from Fisher Scientific, Fair Lawn, NJ. Tris(hydroxymethyl)aminomethane was purchased from 
Amresco, Solon, OH. Culture plates were purchased from Corning Inc., Corning, NY, and the 
sterile disposable syringe filter was 0.2µm PES purchased from Whatman, Clifton, NJ. 
Phosphate buffered saline (PBS) was prepared by dissolving 0.9g of NaCl, 0.111g of 
Na2HPO3 and 0.03g of KH2PO3 in about 90mL of distilled deionized water, adjusting pH to 7 
with 10N NaOH and diluting to 100mL volume with water. Tris-HCl buffer (0.1M) was prepared 
by dissolving 1.2114g of Tris(hydroxymethyl)aminomethane in about 90mL of distilled 
deionized water, adjusting pH to 7.5 with 10N of HCl and diluting to 100mL volume with water. 
5.2.2 Preparation of γ-Oryzanol Micellar Solution 
γ-Oryzanol micellar solution was prepared by first dissolving 0.1mM γ-oryzanol mixed 
with 0.5mM oleic acid, 0.25mM 1-monoolein and 0.3mM lecithin in solvent 
(hexane:isopropanol=3:1). After the solvent was dried under a vacuum evaporator with 
temperature set at 45oC (CentriVap Console, Labconco Inc., Kansas City, MO), 6.6mM sodium 
  
taurocholate in buffer or culture medium free of serum and transferrin was added to the dried 
lipids and then ultrasonicated (Sonic Dismembrator 60, Fisher Scientific, Fair Lawn, NJ) in an 
ice bath for 45 minutes. The micellar solution was free of precipitate. 
5.2.3 Preliminary Study of In Vitro Digestibility of γ-Oryzanol 
Digestibility of γ-oryzanol was determined by a modified in vitro model (Ames et al., 
1999) to simulate digestion in the human stomach and small intestines. Crystalline γ-oryzanol, 
1mg, or 500µL of 0.2mM γ-oryzanol micellar solution in PBS (1mM oleic acid, 0.5mM 1-
monoolein and 0.6mM lecithin, without sodium taurocholate) was mixed with 3mL of distilled 
water and 2mL of freshly made pepsin solution (0.32g/mL in 0.1N HCl) and pH was adjusted to 
2 using 6N HCl. After peptic digestion in a shaking water bath at 37oC for 2 hours, 1mL of a 
freshly prepared bile (25mg/mL) and pancreatin (4mg/mL) mixture in 0.1N NaHCO3 was added 
to the digest with pH adjusted to 7 using 0.5N NaHCO3 and incubated at 37oC for 2 hours. 
Digestibility of ferulic acid and stigmasterol (1.0mg crystalline each) were also tested. 
5.2.4 Digestibility of γ-Oryzanol In Vitro by Pancreatic Enzymes, Cholesteryl Esterase, Lipase 
and Phospholipase A2  
To investigate the effect of specific pancreatic enzymes on digestibility of γ-oryzanol, 
CEase, lipase and phospholipase A2 were studied. Each enzyme at a serial concentrations of 0.1, 
1, 10, 100 or 500µg protein/mL was applied to 1mL of 0.1mM γ-oryzanol micellar solution 
containing 0.5mM oleic acid, 0.25mM 1-monoolein, 0.3mM lecithin and 6.6mM sodium 
taurocholate in 0.1mM Tris-HCl buffer (pH 7.5) for 1.5 hour at 37oC, followed by solvent 
extraction, determination of the remaining γ-oryzanol concentrations by HPLC analysis and 
identification of digestion products by a gas chromatography (GC) coupled with mass 
spectrometry (MS) analysis. 
  
5.2.5 Study of γ-Oryzanol Uptake by Human Intestinal Cells In Vitro 
5.2.5.1 Cell Culture 
γ-Oryzanol uptake by human intestines in vitro was investigated by using C2BBe1 cells 
(ATCC CRL-2102). To maintain the cell line, the cells were subcultured every 4 days when 
confluent. The old medium was pipetted out and discarded and the cells were washed with 
0.25% trypsin solution three times. At the third time the trypsin solution remained until the cells 
detached from the flask (about 10 minutes at 37oC). The cell suspension was pipetted up and 
down to break any clumps and subcultured (split ratio 1:3) with new medium (90% DMEM with 
4mM L-glutamine, 1.5g/L sodium bicarbonate and 4.5g/L glucose and supplemented with 
0.01mg/mL human transferrin; 10% fetal bovine serum). For γ-oryzanol uptake experiments, the 
cell suspension was diluted in new medium to 2x105 cells/mL and 1mL was transferred to each 
well (area=2cm2) of the 24-well culture plates, which resulted in 105cells/cm2. For cytotoxicity 
studies, 96-well plates were used and 100µL of the cell suspension was cultured in each well. 
Cell count was performed at each subculture to ensure consistency for each experiment.  
5.2.5.2 Cytotoxicity Study of γ-Oryzanol Micellar Solution Using an MTT Assay 
To study cytotoxicity of γ-oryzanol micellar solution, a 3-(4,5-dimethylthiazol-yl)-2-5-
diphenyltetrazolium bromide (MTT) assay kit was used to measure cell viability in terms of the 
activity of mitochondrial dehydrogenases in living cells. After subculture in 96-well culture 
plates and reaching confluency, the cells were washed gently twice with Hanks balanced salt 
solution (HBSS) and applied at 100µL/well of γ-oryzanol micellar solution prepared in culture 
medium free of serum and transferrin for 2 hours at 37oC. After incubation, the γ-oryzanol 
solution was removed and the cells were gently washed twice with HBSS, followed by 
40µL/well of 1.25mg/mL MTT in HBSS, which has a yellow color. After incubation at 37oC in 
  
the dark for 2 hours, the mitochondrial dehydrogenases of viable cells cleaved the tetrazolium 
ring and yielded purple formazan crystals, which are insoluble in aqueous solution. Then 
100µL/well of MTT solubilization solution containing 10% Triton X-100 plus 0.1N HCl in 
anhydrous isopropanol was added to solubilize purple formazan crystals. Pipetting up and down 
at least 100 times helped solubilization in dense culture situation. Absorbances at 570nm for 
color development and at 690nm for background were read using a microplate 
spectrophotometer (SPECTRAmax® PLUS, Molecular Devices Co., Sunnyvale, CA). An 
increase or decrease of cell numbers after exposure to a test solution would correspond to a 
concomitant change in the amount of purple formazan formed or in the optical density at 
absorbance 570nm. The cell viability under exposure to a test compound was expressed in 
%cellular mitochondrial activity, which was the ratio of absorbance reading difference between 
570nm and 690nm of test compound (A570 − A690) to that of the control (Ao570  Ao690): 
                         A570 − A690 
%Cellular mitochondrial activity  =    × 100% 
                             Ao570  Ao690   
5.2.5.3 Study of γ-Oryzanol Uptake by Cells In Vitro 
C2BBe1 cells were incubated with 1mL/well of the γ-oryzanol micellar solution in 
serum-free and transferrin-free culture medium for 2 hours at 37oC. After incubation, the test 
solution was pipetted out and the cells were washed gently with HBSS twice. The cells were 
lyzed in 400µL/well of 1N NaOH at 37oC for 30 minutes and neutralized by 400µL/well of 1N 
HCl before further γ-oryzanol determination. 
5.2.6 Analysis of γ-Oryzanol and Ferulic Acid Using Solvent Extraction and HPLC 
To determine the remaining γ-oryzanol and ferulic acid concentrations and the 
hydrophobic digestion products after digestion, hexane/ethyl acetate/isopropanol (2:1:1) (×1) and 
  
hexane (×3) extraction was performed for each sample. The organic layers were collected, 
combined and mixed with sodium sulfate anhydrous to remove water. The solvent was 
evaporated under vacuum. The residue remaining was dissolved in mobile phase and 
ultrasonicated to help dissolve if necessary, followed by liquid chromatography to determine 
concentrations of γ-oryzanol and ferulic acid. 
A reverse-phase HPLC system developed by Xu and Godber (1999) was used to 
determine γ-oryzanol and ferulic acid concentrations. It consisted of a pump (Waters 510 HPLC 
Pump, Waters Co., Milford, MA), an autosampler (Waters 715 Sample Processor), a column 
(C18, 25cm×4.6mm diameter, MICROSORB-MV 100 Å, Varian, Walnut Creek, CA) and a UV 
detector (wavelength 330 nm, Waters 486 Tunable Absorbance Detector). The mobile phase was 
methanol, acetonitrile, dichloromethane and acetic acid (50:44:3:3) with a flow rate maintained 
at 1.4 mL/min. One hundred µL of each sample was injected each time. Retention times for γ-
oryzanol and ferulic acid were 5-9 minutes and 1.5 minutes, respectively. Millenium32 software 
(Waters Co., Milford, MA) was used to record the chromatograms and integrate peak areas. A 
standard curve of γ-oryzanol (concentration versus integrated area) was constructed to infer γ-
oryzanol concentration in samples.  
5.2.7 Identification of γ-Oryzanol Digest Products by GC/MS 
After HPLC analysis, the solvent in each remaining sample was evaporated for further 
gas chromatography and mass spectrometry (GC/MS) analysis. Before being injected into 
GC/MS, each sample with dried residue was derivatized using 100µL of trimethylsilylation 
reagents, which were N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 
trimethylchlorosilane (TMCS) (99:1), and 100µL pyridine to remove any possible water, which 
could also react with the trimethylsilylation reagents. After incubation in a shaking water bath at 
  
30oC for 2 hours, all samples were stored at 4oC until GC analysis, which was usually done 
within 24 hours.  
The GC system (Varian CP-3800, Walnut Creek, CA) consisted of a glass injection port 
(splitless, 300oC) and a fused silica capillary column with low polarity (SPB-5, 30m x 0.25mm 
diameter and 0.1µm film thickness, Supelco Inc., Bellefonte, PA). The oven temperature was 
ramped from 100oC to 280oC with heating rate of 3oC/min and helium was the carrier gas 
maintained at a flow rate of 1.0mL/min. One µL of each sample was injected with split ratio 0 
from 0-0.2 minutes and 10000 from 0.2-60 minutes. The GC system was coupled with an MS 
detector (Varian Saturn 2200) with the following conditions: trap temperature 170oC, manifold 
temperature 65oC and transfer line temperature 170oC; axial modulation 3.9 volts; mass range, 
m/z 45-650; EI auto ionization mode: scan time 0.39 seconds/scan, emission current 10µamps, 
pre-scan ionization time 100 µsecond and maximum ionization time 25000 µsecond. 
5.3 Results and Discussion 
5.3.1 Digestibility of γ-Oryzanol In Vitro by Pepsin and Bile-Pancreatin 
The actual digestive process in humans is more complicated than that depicted in this in 
vitro experiment. The capacity of the stomach is 50mL when empty and can expand to 1 to 1.5 
liters when filled (Wardlaw and Insel, 1993). The small intestine, composed of the duodenum, 
the jejunum and the ileum, is altogether approximately 10 feet long. Food stays for 2 to 3 hours 
in the stomach and 3 to 10 hours in the small intestines. Since γ-oryzanol was the only compound 
of interest tested in the absence of the complexity of other foods, which require longer time to 
digest, the scale of the model to study digestibility of γ-oryzanol was reduced but maintained in 
approximately the same ratio with pepsin, bile and pancreatin solutions as the model used by 
  
Ames et al. (1999). For the same reason, the incubation time was also reduced to 2 hours with 
pepsin and then 2 hours with pancreatin. 
The results showed that γ-oryzanol concentrations in both forms of crystalline and 
micellar solution decreased after peptic and pancreatic digestion compared to incubation with 
water (Figure 5.1). Interestingly, the susceptibility of these two forms of γ-oryzanol to digestion 
was not equal. After either peptic or pancreatic digestion, γ-oryzanol recovered from micellar 
solution was less than that recovered from the crystalline form. It may be explained that the γ-
oryzanol in crystalline form, which was insoluble in aqueous solution, was not evenly distributed 
in the solution to react with pepsin and pancreatin while the micellar form was. Additionally, 
even though little chemical digestion occurs in the stomach except protein hydrolysis, %recovery 
of γ-oryzanol decreased more significantly in the form of micelles when incubated with HCl and 
without pepsin, which may indicate that the effects of both low pH and pepsin on structural 
integrity of γ-oryzanol exists. The further contribution of pancreatin to γ-oryzanol degradation 
was also present in both forms of γ-oryzanol, crystalline and micelles, when compared to the γ-
oryzanol recoveries after incubation with NaHCO2 and without pancreatin.  
In regard to the pathway of γ-oryzanol degradation during digestion, one could 
hypothesize that γ-oryzanol might be hydrolyzed by pepsin and the pancreatic enzymes at the 
ester bond since the chemical structure of γ-oryzanol consists of a terpene alcohol or sterol 
esterified with a ferulic acid (Figure 2.2(b)). On the HPLC chromatograms of γ-oryzanol after 
peptic and pancreatin digestion (Figure 5.2), all the γ-oryzanol components decreased and ferulic 
acid, which if present would also absorb at 330nm with the retention time at 1.5 minutes (Figure 
3.1(b)), was not found after either peptic or pancreatic digestion. Also, the further analysis of 













































































































































































































































































































































































































































































































































































































































oryzanol did not increase (Figure 5.3). However, this was inconclusive as to whether or not the 
breakdown of the ester bond occurred. The digestibility of stigmasterol and ferulic acid was also 
studied and the results showed that the concentrations of both decreased after digestions (Figure 
5.4 and 5.5). Thus, if the ester bond of γ-oryzanol is hydrolyzed, the sterols or terpene alcohols 
and ferulic acid produced might be further degraded. Otherwise, degradation of γ-oryzanol might 
undergo a different pathway. 
Absorption and metabolism of γ-oryzanol in rats has been studied by Fujiwara et al., 
1983. In the first 72 hours after oral administration of 14C-labeled at the C-3 position of ferulic 
acid, radioactivity analysis showed that 9.8% of the dose (50mg/kg) was excreted in the urine, 
which was not intact γ-oryzanol. But their results from the experiment of in situ intestinal 
absorption showed that, while 89.4% of the radioactivity remained in the luminal fluid mostly as 
intact γ-oryzanol suggesting γ-oryzanol was poorly absorbed, more than 80% of the absorbed 
radioactivity (=0.16% of the dose) was intact γ-oryzanol, transferred into the mesenteric vein and 
then into portal vein, and 10 to 20% of the absorbed dose was metabolized in the intestinal 
tissues to yield ferulic acid. However, this in situ experiment did not cause the γ-oryzanol to 
undergo digestions in stomach, duodenum and jejunum, where secreted digestive enzymes could 
cause γ-oryzanol degradation to occur.  
The metabolic fate of ferulic acid has also been studied by Booth et al. (1957). In both 
studies, the proposed urinary metabolites of ferulic acid were dihydroferulic acid, vanillic acid, 
m-coumaric acid, m-hydroxyphenylpropionic acid, hippuric acid and m-hydroxyhippuric acid 
(see chemical structures in Figure 2.6). None of these metabolites were found in the digestion 
products in this study, based on the GC chromatograms and identification by the MS spectrum of 










































































































































































































































































































































































































































hexane/ethyl acetate/isopropanol (2:1:1) plus hexane (×3) should be efficient to extract ferulic 
acid and those metabolites if present. However, during that period when the previous studies 
were done, thin layer chromatography was mostly employed and using Rf values to identify γ-
oryzanol and its metabolites may be questionable. More research is required to further delineate 
the digestibility and metabolism of γ-oryzanol. 
Therefore, all the results may imply that γ-oryzanol undergoes a more complicated 
degradation through the gastrointestinal tract rather than the simple breakdown of the ester bond 
between terpene alcohol or the sterol portion of γ-oryzanol and ferulic acid. 
This experiment focused mainly on chemical digestibility of γ-oryzanol with pepsin and 
pancreatin and the digestion products yielded from hexane/ethyl acetate/isopropanol (2:1:1) 
extraction and, therefore, is of a preliminary nature. The effects of gastric and intestinal muscle 
contraction, the movement of the foods in the gastrointestinal tract, the regulation of the enzyme 
secretions, the interrelationships with liver and pancreas and the interrelationship between 
digestive and absorptive processes on digestibility of γ-oryzanol were beyond the scope of this 
study.  
5.3.2 Digestibility of γ-Oryzanol by Pancreatic Enzymes, Cholesterol Esterase, Lipase and 
Phospholipase A2 
Since it was found that γ-oryzanol concentration decreased after peptic and pancreatic 
digestion, it was further studied to determine if three of the pancreatic enzymes, CEase, lipase 
and phospholipase A2, were responsible for γ-oryzanol degradation. The results showed that 
%recovery of γ-oryzanol after incubation with a concentration of CEase higher than 10µg 
protein/mL significantly decreased in a CEase concentration-dependent manner (p<0.05) (Figure 
  
5.6). On the other hand, the %recovery after incubation with lipase or phospholipase A2 was not 
in a concentration-dependent manner and the differences were not as pronounced as with CEase.  
Furthermore, on the HPLC chromatograms of γ-oryzanol after digestion by pancreatic 
enzymes (Figure 5.7), campesteryl ferulate and sitosteryl ferulate decreased more obviously, 
which may imply that they were more susceptible to pancreatic enzyme digestion. The digestion 
products of γ-oryzanol incubated with CEase were further analyzed by GC/MS and it was found 
that the amount of campesterol and sitosterol increased (Figure 5.8), which may be because 
campesteryl ferulate or sitosteryl ferulate was hydrolyzed by CEase at the ester bond to produce 
campesterol or sitosterol and ferulic acid. However, ferulic acid was not found on any of the 
HPLC and GC chromatograms.  
The reason that campesteryl ferulate and sitosteryl ferulate were more susceptible than 
the other components of γ-oryzanol to CEase may be due to the similarity of their chemical 
structures with cholesterols. Their ring structures are identical with cholesterol (Figure 2.2), as 
they have neither the dimethyl groups at C-4 position nor the methyl group at C-14 position, 
while some of the other γ-oryzanol components do. The side chain structures have only an extra 
methyl group difference at C-24 position for campesteryl ferulate and an extra ethyl group for 
sitosteryl ferulate. This could also explain that the amount of campesteryl ferulate decreased 
more after peptic and pancreatic digestion. 
Similarly, none of the urinary ferulic acid metabolites, dihydroferulic acid, vanillic acid, 
m-coumaric acid, m-hydroxyphenylpropionic acid, hippuric acid and m-hydroxyhippuric acid, 
summarized by Fujiwara et al., 1983, and Booth et al., 1957, were found in this study, according 
to the GC chromatograms and the identification on the MS spectrum of the CEase, lipase and 
Figure 5.6. Digestibility of γ-oryzanol in vitro by cholesterol esterase 
(CEase), lipase or phospholipase A2 after incubation for 









































































































































































































































































































































































































































































































































































































































































































































































phospholipase A2 digestion products of γ-oryzanol. This might suggest that ferulic acid was 
further degraded in a different pathway. 
Sterol specificity of CEase has been studied by Swell et al. (1954) who summarized that 
cholesterol, sitosterol and stigmasterol esters with butyric acid were hydrolyzed very rapidly 
while the hydrolysis of their esters with oleic acid was not as rapid. The order of hydrolytic 
activity in the first 4 hours was cholesteryl oleate>sitosteryl oleate>stigmasteryl oleate. The 
results from our study may also provide some additional information about the specificity of 
CEase, which indicated that the specificity of pancreatic CEase was found not only for 
cholesterol esters, in this case cholesteryl oleate, but also for campesteryl ferulate and sitosteryl 
ferulate. 
5.3.3 Study of γ-Oryzanol Uptake by Human Intestinal Cells In Vitro 
First of all, the cytotoxicity results showed that 0.1mM γ-oryzanol in micellar solution 
did not decrease cellular mitochondrial activity after 2-hour incubation at 37oC, compared to the 
control, serum-free and transferrin-free culture medium (Figure 5.9). Secondly, since NaOH was 
used as the cell lysis solution, the effect on γ-oryzanol hydrolysis was also studied by incubation 
of γ-oryzanol with 1N NaOH without cells at 37oC for 30 minutes. It was found that %recovery 
of γ-oryzanol was 97.7% and, therefore, cell lysis solution would not cause the degradation of 
the recovered γ-oryzanol if γ-oryzanol was absorbed. Thirdly, the uptake of intact γ-oryzanol by 
cells was not detected after 2-hour incubation at 37oC. Longer incubation time was not studied 
because the cells were vulnerable to the micellar solution, which was required to prepare γ-
oryzanol in aqueous environment. However, the same cell model was also used to study 
cholesterol uptake in vitro, and cholesterol uptake by cells was detected under the same 



























Figure 5.9. Cytotoxicity study of γ-oryzanol micellar solution incubated 
with human intestinal cells C2BBe1 at 37oC for 2 hours
  
oryzanol uptake with those after the control (emulsion without γ-oryzanol) uptake, there were no 
differences in detected compounds. 
Compared to the Fujiwara study on the in situ intestinal absorption experiment, they 
concluded that 89.4% of the dose was found in the luminal fluid 50 minutes after administration, 
mostly as intact γ-oryzanol, and suggested that γ-oryzanol was poorly absorbed.  
5.4 Conclusion 
Digestibility of γ-oryzanol focusing on peptic and pancreatic digestions was studied. A 
cell model using human intestinal cells in vitro was also developed to study whether or not γ-
oryzanol uptake into cells occurred. 
From all the information provided by this study, it may be implied that in the small 
intestines, the ester bond of γ-oryzanol, especially campesteryl ferulate and sitosteryl ferulate, 
was broken down by CEase and produced terpene alcohols or sterols and ferulic acid, both of 
which may be further broken down since they were not found in the peptic and pancreatic 
digestion products. Even though the degradation of γ-oryzanol, other than steryl ferulates, by 
CEase was not as noticeable, they may be degraded by other substances in pancreatin since their 
recoveries also decreased. The degradation of γ-oryzanol in the stomach may undergo a different 
pathway because sterols or terpene alcohols were not found after peptic digestion. Moreover, γ-
oryzanol in micellar solution was degraded more readily than in the crystalline form, proving 
that micelle formation is necessary for lipid digestion in the gastrointestinal tract since the 
surface area of dietary lipids in micelles increases and consequently the accessibility of the lipids 
to the digestive enzymes in aqueous environment increases. 
As for the γ-oryzanol uptake by human intestinal cells in vitro, intact γ-oryzanol uptake 
by cells was not detected after 2-hour incubation. In this regard, relative to research that might be 
  
conducted in the future, identification of the digestion products, their cytotoxicity and uptake by 
human intestinal cells are suggested in order to further understand the digestibility of γ-oryzanol. 
Furthermore, there has been little information provided relative to biotransformation of γ-
oryzanol and its digestion products by microflora in the human colon. This should also be 
explored in the future since it has been a hot issue to develop functional foods to improve the 
health of the human colon and to possibly protect against gut-related diseases.  
  
CHAPTER 6. CONCLUSION 
 
In this study, in vitro cell models were developed and were used to study the 
functionality, antioxidant activity and hypocholesterolemic capacity, and digestibility of γ-
oryzanol. The cell lines chosen had a fast metabolism and consequently could be used to study 
the functionality of γ-oryzanol in a relatively rapid manner. The general parameters that are 
critical and vital when using cell models as tools for functionality experiments, are 1) the 
emulsion preparation of hydrophobic compounds for cell models, 2) the consistent management 
of cell culture, and 3) the selection of cell viability detection methods compatible with the cell 
lines and the test substances. 
An in vitro cell model using SVEC4-10 mouse lymph endothelial cells was established 
and proven to be capable of distinguishing antioxidant activity of γ-oryzanol, ferulic acid, the 
three major components of γ-oryzanol, cycloartenyl ferulate, 24-methylene cycloartanyl ferulate 
and campesteryl ferulate, as compared with α-tocopherol. tBHP was the oxidizing agent, whose 
concentration and incubation time combinations were very critical, and the MTT assay was 
chosen for cell viability determination because it had high response signals and did not interfere 
with the test substances of interest. Four situations were designed to test whether or not the 
compounds of interest might protect cells from tBHP oxidation, including 1) being 
simultaneously present with tBHP and cells, 2) being associated with cells before tBHP 
oxidation but not present with tBHP, 3) being associated with cells before and during tBHP 
oxidation, and 4) interacting with tBHP before it reached cells. Generally, γ-oryzanol and ferulic 
acid were found to possess antioxidant activity in terms of preventing cellular mitochondrial 
damage due to tBHP oxidation. When γ-oryzanol or α-tocopherol was simultaneously present 
with cells and tBHP, their antioxidant activity was not significant. When associated with the 
  
SVEC4-10 cells before tBHP oxidation, ferulic acid had higher antioxidant activity than γ-
oryzanol and α-tocopherol at the early stage of oxidation (0 to 30 minutes) while γ-oryzanol and 
α-tocopherol tended to have higher antioxidant activity than ferulic acid at the late stage of 
oxidation (30 to 60 minutes). The three major components of γ-oryzanol generally had higher 
antioxidant activity than γ-oryzanol and in the situation when associated with cells before and 
during tBHP oxidation, they presented more powerful antioxidant activity than α-tocopherol. 
Among these three major components of γ-oryzanol, 24-methylene cycloartanyl ferulate was 
found to be relatively more effective. A synergistic antioxidant activity among γ-oryzanol, 
ferulic acid and α-tocopherol was also found when simultaneously present with tBHP. Since the 
quantity of γ-oryzanol in rice bran is much greater than vitamin E, γ-oryzanol may play a more 
important role as an antioxidant to support the potential functional value of rice bran. 
Regarding the hypocholesterolemic capacity of γ-oryzanol, this is the first time that the 
possible mechanism for this γ-oryzanol function has been approached. This study postulated 
relative to the aspects that γ-oryzanol may affect and then developed a model to investigate the γ-
oryzanol effect from each aspect. An in vitro cell model using human intestinal cells (C2BBe1) 
accompanied with GC/MS for cholesterol analysis was developed and used to detect cholesterol 
uptake into cells in vitro. The results suggested that the intact γ-oryzanol was poorly absorbed by 
intestinal cells, therefore, it was speculated that the effect of γ-oryzanol may take place in the 
lumen of the gastrointestinal tract and the effect was on the availability of cholesterol for uptake 
into cells. The results suggested activity from three standpoints. 1) γ-Oryzanol may affect the 
availability of cholesteryl esters by reducing their micellar solubility because the uptake of 
cholesteryl oleate was not found and the hydrolysis catalyzed by CEase to produce free 
  
cholesterol was necessary. 2) Since the function of CEase to facilitate cholesterol uptake was not 
found, γ-oryzanol may inhibit the hydrolytic function of CEase, which was essential for the 
hydrolysis of cholesteryl esters and free cholesterol production. 3) Because it was found that 
CEase and phospholipase A2 did not promote the uptake of free cholesterol, γ-oryzanol may 
affect the availability of free cholesterol for uptake by decreasing its micellar solubility.  
Digestibility of γ-oryzanol (in crystalline or in micellar solution) after peptic and 
pancreatic digestions and the uptake of intact γ-oryzanol into cells were studied by an in vitro 
cell model using human intestinal cells (C2BBe1). γ-Oryzanol was found to be degraded after 
peptic and pancreatic digestions and the degree of degradation was higher in micellar solution 
than in crystalline, proving that micelle formation is necessary for lipid digestion in the 
gastrointestinal tract. The reasons may be relative to increased surface area of dietary lipids in 
micelles and the consequence of increased accessibility of the lipids to the digestive enzymes in 
aqueous environment. The effect of three pancreatic enzymes, CEase, lipase and phospholipase 
A2, on γ-oryzanol degradation was further studied. The results showed that the ester bond of γ-
oryzanol, especially campesteryl ferulate and sitosteryl ferulate, was broken down by CEase and 
produced triterpene alcohols or sterols and ferulic acid. However, in the peptic and pancreatic 
digestion products, triterpene alcohols or sterols and ferulic acid were not found and it may 
suggest further degradation. The degradation of γ-oryzanol in the stomach may undergo a 
different pathway because sterols or triterpene alcohols were not found after peptic digestion. 
Additionally, the uptake of intact γ-oryzanol into cells was not detected, while cholesterol uptake 
was, after 2-hour incubation.  
Finally, more research is required in order to further understand the digestive and 
metabolic fates of γ-oryzanol, including the degradation reactions, the identification of the 
  
digestion products, the toxicity and uptake of the digestion products into the human intestinal 
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APPENDIX I. SAS CODES 
 
A. Antioxidant Activity 
dm 'log;clear;output;clear;'; 
options ps=58 ls=98 nodate pageno=1; 
 
data format1combo; 
input day column type $ oxtime activity @@; 
cards; 
1 1  em  0 100.70 1 2  em  0  99.3 1 1  em 15  94.5  
1 2  em 15  93.35 ...              
5 1   f 30  56.6 5 2   f  30  76.6 5 1   f 45  68.4  
5 2   f 45  68.1 5 1   f  60  39.2 5 2   f 60  55.2; 
run; 
proc sort; 




classes day column type oxtime; 
model activity=type|oxtime/Ddfm=Satterth; 






B. Cholesterol Uptake 
dm 'log;clear;output;clear;'; 
options ps=58 ls=78 nodate pageno=1; 
 
Data cholesteroluptake; 
Input trial block trt $ sub uptake @@; 
Cards; 
1 1 Em   1 18.3745  
1 1 C   1 15.7103  
... 
6 2 CO+ory+CEase 1 12.7126 




classes trial block trt; 
model uptake=trt/Ddfm=Satterth; 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX III. DATA OF CHOLESTEROL UPTAKE EXPERIMENTS 
(a) Effect of γ-oryzanol on micellar solubility of cholesterol and cholesteryl oleate  
(n=2 × 2 replications). 
 
%recovery of cholesterol, cholesteryl oleate or oryzanol in supernatant 
cholesterol + ethanol 100.00 ± 9.52 
cholesterol + oryzanol 91.50 ± 9.52 
cholesteryl oleate + ethanol 100.00 ± 9.52 
cholesteryl oleate + oryzanol 86.08 ± 9.52 
oryzanol + control emulsion 100.00 ± 0.50 
oryzanol + cholesterol 16.78 ± 0.50 
oryzanol + cholesteryl oleate 4.82 ± 0.50 
 
(b) Effect of γ-oryzanol preincubated with cholesterol for 0, 1, 2 or 6 hours on cholesterol uptake 
into human intestinal cells in vitro, 2 hour, 37oC. (n=2×3 replications). 
 
cholesterol uptake (µmol cholesterol/mg cell protein) 
cholesterol 18.52 ± 3.82 
preincubation of cholesterol for 6 hours 16.77 ± 3.61 
cholesterol + oryzanol 17.82 ± 2.65 
preincubation of cholesterol + oryzanol for 1 hour 17.33 ± 3.18 
preincubation of cholesterol + oryzanol for 2 hours 16.16 ± 2.77 
preincubation of cholesterol + oryzanol for 6 hours 14.05 ± 3.02 
control emulsion 15.58 ± 2.36 
 
(c) Effect of γ-oryzanol preincubated with cholesteryl oleate for 0 or 1hour before cholesterol 
esterase-facilitated hydrolysis on cholesterol uptake into human intestinal cells in vitro, 2 
hour, 37oC. (n=2×3 replications). 
 
cholesterol uptake (µmol cholesterol/mg cell protein) 
cholesterol 18.52 ± 3.82 
cholesteryl oleate + CEase 18.97 ± 2.51 
cholesteryl oleate + oryzanol + CEase 16.01 ± 2.77 
preincubation of (cholesteryl oleate) for 1 hour + CEase 19.14 ± 3.18 
preincubation of (cholesteryl oleate + oryzanol) for 1 hour + CEase 14.89 ± 3.18 
cholesteryl oleate 16.81 ± 2.37 
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